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In the past two decades, remarkable progress has been made in the development of 
surgical techniques for bone reconstruction, significantly improving clinical outcomes. 
However, major reconstruction after trauma or cancer is still limited by the paucity of 
autologous material and donor site morbidity. Recent advances in the field of tissue 
engineering have generated new approaches for restoring bone defects.  In spite of this 
progress, the necessity of suitable blood supply to ensure cell function is a major 
challenge in the development of more complex and functional grafts.  Many 
investigators have successfully demonstrated the use of different strategies including 
growth factor delivery and in vitro coculture of ECs and MSCs to develop vascular 
structures. MSCs have the ability to secrete a wide range of bioactive cytokines and 
growth factors that can influence nearby cells via paracrine signaling. This crosstalk 
 
between ECs and MSCs is mutually beneficial, as ECs enhance osteogenic 
differentiation of hMSCs through direct cell-cell contact and paracrine signaling. In the 
native environment of cortical bone, both cell populations, osteogenic and 
vasculogenic, follow a unique well-defined pattern, called osteons.  
The goal of this proposed study was to develop a novel bio-inspired and vascularized 
bone construct, harvesting the synergistic effects of pro-angiogenic growth factor 
delivery and coculture of ECs and MSCs. To address this goal, we first developed 
mesoporous calcium deficient hydroxyapatite apatite microparticles, with biological 
properties closer to bone than commercially available hydroxyapatite, and capable of 
efficiently loading and sustainably releasing pro-angiogenic growth factors. We then 
demonstrated the successful fabrication of a novel bio-inspired 3DP fibrin-PCL 
composite scaffold, with mechanical strength comparable to bone. The utilization of 
these scaffolds in constructing osteons for bone regeneration demonstrated the 
promising capacity of the construct to improve neovascularization.  In light of these 
results, we hypothesized that cell placement or patterning could play a critical role in 
neovascularization. Which lead us to investigate the role of distance between cell 
populations, introduced via 3D printing, in ECs/MSCs crosstalk. Our results suggested 
that controlling the distance between ECs and MSCs in coculture, using 3D printing, 
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Chapter 1: Introduction 
 
The need for engineered bone tissue. 
With more than one million procedures performed in the United States 
annually, plus an additional 2.2 million worldwide, bone is the second most 
transplanted tissue 1 2. Those numbers are expected to increase in the next decade due 
to a variety of factors, including an aging population and deteriorating physical activity 
levels 3.  
Bones have two main purposes, structural and metabolic, accomplished through 
maintenance of a rigid skeletal extracellular matrix (ECM) 4-5.  On the macroscopic 
scale, bone is made of dense cortical bone forming an outside shell and cancellous bone 
within the marrow cavity. Bone tissue is a mineralized connective tissue and is formed 
by three different cell types: osteoblasts - which differentiate from pluripotent 
mesenchymal cells (MSCs), osteocytes, and osteoclasts 6.  Calcium phosphates, in the 
form of hydroxyapatite, are the principal mineral content of bone’s extracellular matrix 
(ECM), making up to 70% of the ECM. The organic matrix (22%) consists mostly of 
type I collagen (90% of the organic matrix) 7,8. (See Appendix 1:  A brief summary of 
bone biology. for a more detailed summary of bone biology). Additionally, bones are 
well known for their innate healing abilities: osteoblasts, responsible for the secretion 




regenerate and repair damaged bone tissue; yet this ability can be undermined by the 
severity and size of the injury or disease 9.  
For larger bone defects repair, allogenic, autologous and prosthetic grafts are 
often used.  Non-immunogenic and histocompatible autografts are currently the gold 
standard for bone grafts, as they are able to achieve osteoconduction, osteoinduction, 
and osteogenesis 10,11.  Although autografts and allografts have proven successful in 
many cases, they present significant drawbacks, including limited sources, a 
requirement for secondary operations, risks of disease transmission and 
immunoreactions 12–14. In addition, extensive studies have shown that with autologous 
grafts, complications can affect 10 to 30% of patients 15. Other sources of materials 
have been used for bone repair including metals, ceramics, and polymers. However, 
metals can provide sufficient physical strength but have poor patient site integration, 
and are unable to be remodeled 16, while ceramics are biocompatible and are 
osteoconductive but they tend to be brittle 17. 
Bone tissue engineering (BTE) is a promising alternative, for the treatment of 
bone defects that will ideally eliminate the issues described above 18. BTE aims at not 
only repairing bone defects but also enhance bone regeneration allowing host tissue in-
growth 19. Tissue engineering strategies are based on several key components: (i) a 
biocompatible porous scaffold mimicking the bone’s natural environment that will 
allow, (ii) osteogenic cells to lay down new bone matrix directed by, (iii) morphogenic 
signals. Tremendous progress over the last decades has been made in BTE, with an 




1990s 20. But despite the increasing research expenditure and discoveries, there is still 
a major discrepancy between scientific research efforts and clinical applications. 
 
The need for vascularized engineered bone tissue. 
Vascularization is a crucial process during the growth and development of bone, 
yet it remains one of the main challenges in the reconstruction of large bone defects 21. 
Vasculature is a requirement when engineering most tissues. The diffusion distance for 
nutrients and oxygen implicit to cell survival is limited (150–200 µm) and this can lead 
to necrosis in the center of the supportive scaffolds 22.  Many studies in BTE have relied 
on the spontaneous organization of endothelial cells, and uncontrolled angiogenesis, to 
form a vascular network. However, technologies to control and direct 
neovascularization within a mineralized construct have been developed to improve 
clinical outcomes from bone grafting procedures. Many authors have successfully 
demonstrated the use of different strategies to develop vascular structures, including 
growth factor delivery 23, channeled scaffolds 24, perfusion bioreactors 25, cell 
cocultures 26, cell functionalization 27, and in vivo systems 28.  
One of the most traditional methods to initiate angiogenesis and osteogenesis 
include delivering growth factors (GFs), such as vascular endothelial growth factor 
(VEGF) and bone morphogenetic proteins (BMPs) 29. Even though delivery of growth 
factors is known to enhance angiogenesis and osteogenesis in construct, their dosage 
and timing must be tightly controlled. Several particle‐based systems, either naturally 
or synthetically derived, have been developed to deliver growth factors (GFs), 




explored in Chapter 2: Development of Porous Hydroxyapatite Microparticles for the 
Exogenous Delivery of VEGF, which summarized our effort to develop porous 
osteoconductive hydroxyapatite microparticles has a novel way to encapsulate and 
deliver VEGF.   
Because vascularized bone regeneration requires cross-communication 
between multiple cell types, the use of in vitro coculture of human umbilical vein 
endothelial cells (HUVECs) and human mesenchymal stem cells (hMSCs) is also one 
of the most explored options, as it allows for concurrent creation of a vascular network 
as well as the target tissue 30–32. It is well established that both cell types secrete specific 
growth factors that are mutually beneficial. For example, endothelial cells are known 
to secrete growth factors such as insulin growth factor-1 33, endothelin-1, and bone 
morphogenic protein-2, promoting osteogenic growth and differentiation of the MSCs 
34. In most cases, both cells population are either seeded onto or encapsulated into a 
scaffold in a somewhat random manner. However, additive manufacturing (AM), or 
3D printing has emerged in the recent years as a promising method for the fabrication 
of porous scaffolds with a higher resolution, accurate cell patterning, and recapitulating 
complex hierarchical structures. The use of 3D printing to create cell-laden scaffolds 
for BTE is further explored in Chapter 3: Cell-Laden 3D Printed Scaffolds for Bone 
Tissue Engineering. Thanks to 3D printing technologies, we developed a bio-inspired 
coculture system, inspired by osteons found in cortical bones, in order to enhanced 
neovascularization of the scaffolds. The results of this study are detailed in Chapter 4: 




 Finally, research efforts by a number of groups have focused on strategies that 
can enhance the secretory function of MSCs and ECs in cocultures. Recently, studies 
suggested that cell-cell communication and paracrine secretion can be affected by the 
substrate microarchitecture 35, mechanical environment 36 or the matrix stiffness 37. 
However, little is known about the effect of cell patterning and the distance between 
cell populations on their crosstalk. The fact that different tissue types, such as osteons 
in bones, have precisely regulated architecture, combined with positive results from 
Chapter 4, suggests that characteristic features related to the number, types, and spacing 
of cells might be critical to tissue function. This led us to investigate how the distance 
between cells in different 3D printed co-cultures affected angiogenesis by modulating 
cell-cell communication. Our findings are presented in Chapter 5:  Cell-to-Cell distance 




As discussed above, most bone tissue engineering strategies failed to reach clinical 
stages. The need for new technologies to control and direct neovascularization is 
critical in order to obtain viable bone graft. In this dissertation, we focused specifically 
on developing bio-inspired vascularization strategies, based on what is found in the 
native bone. Specifically, this work aims to provide an alternative approach to the 
fabrication of vascularized bone tissue engineering scaffolds, through the development 
and characterization of a novel growth factor delivery system and novel 3D printed 




1. Develop mesoporous calcium deficient hydroxyapatite apatite 
microparticles, capable of efficiently loading and sustainably releasing pro-
angiogenic growth factors. 
2. Establish a 3D printed bio-inspired scaffold that promotes bone 
regeneration and neovascularization.  
 a. Develop a 3D printed biphasic osteon-like scaffold that is biocompatible, and 
possess mechanical properties close to cortical bone.  
 b. Investigate the cross talk between ECs-MSCs within bio-inspired 3D printed 
cocultures. 
 c. Demonstrate the positive healing capacities (bone formation and 
neovascularization) of optimized 3DP scaffolds in a rat cranial defect. 
The successful completion of these objectives will result in the development of a unique 
method of encapsulating VEGF that could hold great potentials for drug-delivery 
applications and a broad utility in many bone tissue engineering applications where 
sustained release of factors in a local environment is advantageous.  In addition, the 
development of bio-inspired osteon-like construct could potentially be developed as 
scaffolds in vascularized bone tissue engineering. We see this as a major step towards 
creating a vascularized tissue-engineered bone construct of a relevant size that will fill 







Chapter 2: Development of Porous Hydroxyapatite 
Microparticles for the Exogenous Delivery of VEGF 
 
Introduction 
One of the biggest challenges faced in the field of bone tissue engineering is promoting 
the growth of vasculature within engineered tissues, to enable sufficient engraftment 
and integration within the host 38. A variety of approaches have been developed for this 
purpose. The delivery of vascular endothelial growth factor (VEGF) is a particularly 
promising way to enhance angiogenesis due to the fact that it has the ability to increase 
vascular network formation and vascular permeability 39,40 resulting in increased blood 
flow and access to the defect site by progenitor cells. 
Hydrogels are the most commonly reported delivery system for growth factors (GFs) 
but are generally unable to release GFs for extended periods 41,42. Moreover, 
uncontrolled delivery of growth factors can also lead to heterotopic tissue formation or 
hematomas in soft tissues. This occurs as a result of GFs leakage into other areas of the 
body, due to the uncontrolled manner in which the GF is released 43. This has led to the 
emergence of GFs delivery systems in the form of microparticles, which protect the GF 
while controlling its release 44,45. The scientific literature describes numerous 
methodologies for encapsulating drugs in a variety of matrix materials  46,47. To be used 
as a GFs carrier, the material forming the microparticles must have the ability to (i) 
incorporate a drug either physically or chemically, (ii) retain the drug, (iii) be gradually 
degraded, and deliver the drug in a controlled manner over time 48. Calcium phosphates 




Hydroxyapatite (HA), (Ca10(PO4)6(OH)2, HA), is a form of CaP with a Ca/P ratio of 
1.67. HA is widely used in bone tissue engineering due to its structural and chemical 
similarities with the key mineral component of bone 7,49–51. HA is also used in 
chromatography for purification and separation as an absorbent agent to its excellent 
absorption of many molecules 52. Favorable biological properties, which includes 
biocompatibility, bioaffinity, osteoconduction and in certain cases, osteoinduction 53, 
of HA over other ceramics are some of the reasons that CaP systems are increasingly 
being explored as drug delivery systems for orthopedics, dental and maxillofacial 
applications. Porous hydroxyapatite microparticles (HAp) can be prepared according 
to a great diversity of methods, the simplest being chemical precipitation 54.  
In the present study, the overall objective was to enhance the regenerative capacity of 
tissue engineering scaffolds through the incorporation of therapeutic GFs. Specifically, 
collagen scaffolds were functionalized with VEGF‐releasing hydroxyapatite particles, 
in an attempt to engineer a material capable of localizing and sustaining the release of 
VEGF over extended periods. We hypothesized that a synthetic system presenting an 
osteoconductive surface and capable of delivering an angiogenic growth factor in a 
localized and sustained manner would enhance osteogenesis as well as angiogenesis. 
To this end, the first aim was to develop microparticles and characterize their size, 
chemical properties and Ca/P ratio to validate the formation of hydroxyapatite. The 
second aim was to evaluate the osteogenic potential of HAp when cultured with 
mesenchymal stem cells (hMSCs) and compare it to commercially available 




of VEGF in the HAp and assess the angiogenic potential of the VEGF-HAp when 
culture with endothelial cells.  
 
Materials and Methods 
Microparticles Synthesis and Characterization 
Synthesis. All chemicals, including calcium chloride anhydrous (CaCl2), sodium 
carbonate anhydrous (Na2CO3), disodium phosphate dodecahydrate 
(Na2HPO4·12H2O), aspartic acid (Asp), and sodium dodecyl sulfate (SDS) were 
purchased from Sigma (St. Louis, MO). Hydroxyapatite particles (HAp) were 
synthesized in a two-step reaction previously described elsewhere 55 (Figure 1a). 
Aspartic acid and sodium dodecyl sulfate were used as a surfactant to form hollow 
calcium carbonate (CaCO3) sacrificial template. HAp was then formed by an anion 
exchange process between CaCO3 and disodium phosphate dodecahydrate (Na2HPO4, 
12H2O). Briefly, two solution were prepared: (i) 0.1 mol/L of CaCl2, 0.1 mol/L of 
Na2CO3 and 0.5 g/L of Asp, and (ii) 0.1 mol/L of CaCl2, 0.1 mol/L of Na2CO3, 0.5 
g/L Asp and 30 mmol/L SDS. CaCO3 crystals were precipitated by rapidly pouring 
solution (i) into solution (ii), and stirring for 1 h at 40 °C. Afterward, an equal volume 
of 0.03 mol/L Na2HPO4-12H2O was added to the CaCO3 solution dropwise, and 
stirred at a constant rate of 200rpm, for 3h at 50 °C and pH10. After 3h, the collected 
particles were filtered off, rinsed in distilled water and washed with ethanol. The 
particles were flash-freeze in liquid nitrogen before being dried in a lyophilizer.   
Microparticles morphology & size distributions. The shape and morphology of the 




SEM) (Hitachi SU-70, Japan). The particle size distributions were measured using a 
Mastersizer S apparatus (Malvern Instruments, United Kingdom), based on dynamic 
light scattering (DLS). For each analysis, 50 mg of particles in suspension were loaded 
into the instrument to monitor their sizes and deviations. 
X-ray photoelectron spectroscopy (XPS). The chemical composition of the particles 
and their calcium-phosphate ratio was measured using a high sensitivity Kratos AXIS 
165 spectrometer (Kratos Analytical Ltd, United Kingdom). 
X-ray powder diffraction (XRD) patterns were examined under a Bruker Apex2 
diffractometer (Brucker, Billerica, MA).  
 
Cell Culture 
hMSCs (RoosterBio, Frederick, MD) were cultured in RoosterBasal Media 
supplemented with RoosterBooster, as per the manufacturer's specifications. Cells were 
expanded on tissue culture polystyrene flasks for 5 days and grown to 90% confluency 
before being passaged using trypsin/EDTA. Cells at passage P3 were used for the 
experiments. The osteogenic media was formulated by supplementing growth media 
(Gibco, Carlsbad, CA) with 100nM dexamethasone (Sigma, St. Louis, MO), 10mM β-
glycerophosphate, and 173 mM ascorbic acid (Sigma). HUVECs (Lonza) were cultured 
in EBM‐2 Basal Medium (Lonza) supplemented by EGM‐2 SingleQuot Kit. Cells were 
expanded on tissue culture polystyrene flasks with media changes every 3 days and 
grown to 80% confluency before being passaged using trypsin/EDTA. Cells at passage 




Live/Dead Assay. Cell viability was assessed incubation using a Live/Dead assay 
(Invitrogen) following standard protocols. HAp (2mg/ml) and hMSCs (1.106 cells/ml) 
were suspended in 4 mg/ml type I collagen (Corning) and scaffolds were formed by 
pipetting 150 µl of the cells/HAp/Collagen solution in a 12 wells plate and incubated 
15 min at 37 °C to crosslink. After 24h culture in media, the scaffolds were incubated 
in 2 mM ethidium homodimer and 4 mM calcein AM (Molecular Probes) for 30 min. 
Fluorescent and brightfield images were then taken using an inverted microscope 
(Nikon Eclipse Ti2). 
 
Growth factor loading and VEGF release study.  
The typical drug loading and in vitro release experiments were performed as follows. 
VEGF (Sigma) adsorption to HA was carried out by incubating 2mg/ml HAp into a 
centrifuge tube containing a solution of 6ng/ ml of VEGF (C0).  Store-bought 
hydroxyapatite (<200nm) (SBp) (Sigma, St. Louis, MO) were used as a control. The 
solutions were then incubated at 37°C for 1 h on a shaker in order to achieve maximum 
loading. After centrifugation, the VEGF-loaded microparticles (HAp or SBp) were 
dried at room temperature under a vacuum overnight. Samples of the supernatants were 
frozen for later analysis. The concentration of VEGF (C1) contained in the supernatant 
was determined by Enzyme-Linked Immunosorbent Assay (ELISA) (Abcam, 
Cambridge, MA). The VEGF-loaded samples were referred to as VEGF-HAp or 
VEGF-SBp.  
 
The rate at which VEGF molecules were released from freestanding microparticles in 




25 mg samples, and incubated at 1 mg/mL, shaking at 37°C.  At each predetermined 
time interval, 200 μL of solution was removed from the vial and flash frozen for later 
analysis.  200 μL of PBS was replaced in each vial in order to maintain a constant 
volume.  After the collection of samples from all time points, the extracted PBS was 
analyzed using an ELISA (Abcam, Cambridge, MA) to determine VEGF 
concentration. 
 
Osteogenic/Angiogenic Potential Experiments 
For all experiments, 2mg/ml of particles (HAp or SBp) and 1.106 cells/ml were 
suspended in 4 mg/ml type I collagen (Corning) and scaffolds were formed by pipetting 
150 µl of the cells/HAp/Collagen solution in a 12 wells plate. Scaffolds containing no 
hydroxyapatite were used as controls. For osteogenic experiments, hMSCs were used 
and cultured in osteogenic media for 14 days along with HAp or SBp. For angiogenic 
experiments, HUVECs were used and grown in growth media for 7 days, along with 
VEGF-HAp and VEGF-SBp.  
DNA quantification Assay. Scaffolds from each group (n=3) were collected after 0 and 
7 days of culture (HUVECs) and 0 and 14 days of culture (hMSCs). Cells were isolated 
from collagen hydrogels by dissolution in 2 mg/mL collagenase (Sigma) for 30 min at 
37°C and a cell pellet was formed by centrifugation. Total DNA was isolated using 
DNeasy Blood and Tissue Kit (Qiagen) according to the manufacturer instructions. 
DNA content was quantified using the PicoGreen DNA assay (Invitrogen) following 




2H-tetrazolium-5-carboxanilide) (Sigma) assay was performed, following the 
manufacturer’s instructions, at the same time point on all groups to quantify. 
Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR). After 0, 7 
and 14 days (hMSCs) or 0 and 7 days (HUVECs) of culture, scaffolds from each group 
were collected. To isolate mRNA from the cells, the scaffolds were dissolved in 
collagenase (Sigma) for 30 min at 37°C and cells were collected by centrifugation. 
Total RNA was isolated with Trizol Reagent (Invitrogen, Carlsbad, CA) following the 
supplier's protocol. Reverse Transcription was performed using TaqMan Reverse 
Transcription Reagents (Applied Biosystems, Foster City, CA) following the supplier's 
protocol. qRT-PCR was performed using TaqMan PCR Master Mix and TaqMan Gene 
Expression Assays for either bone morphogenetic protein 2 (BMP2) and osteocalcin 
(OCN) or vascular endothelial growth factor A (VEGFA) and platelet endothelial cell 
adhesion molecule (PECAM). Quantification of target genes was performed relative to 
the reference GADPH gene. The mean minimal cycle threshold values (Ct) were 
calculated from triplet reactions. 
Von Kossa Staining.  After 14 days of culture in osteogenic media, hMSCs scaffolds 
from each group were fixed in 4% paraformaldehyde (PFA) (Sigma) for 15 min. The 
scaffolds were then dehydrated for histological processing in a series of ethanol 
dilutions (75%, 90%, 100%), embedded in paraffin (Fisher Scientific), and sectioned 
using a microtome (Leica) into 5-micron-thick sections. For the Von Kossa staining, 
the sections were incubated in 2.5% (w/v) silver nitrate for 20 min under UV light, 






The scratch wound assay is a simple, quick and inexpensive method to quantify ECs 
migration. It is based on the ability of EC to fill an area that has been mechanically 
‘wounded’ using a pipette tip on a confluent monolayer of ECs 56. HUVECs were 
seeded in 48 well plates at a density of 30,000 cells per well, and incubated for 24h or 
until a uniform monolayer was formed.  The monolayer was then “scratched” using a 
pipette tip to create a linear gap through the middle of each well. Growth medium 
supplemented with 0.5 mg/ml VEGF/HAp or 0.5 mg/ml VEGF/SBp were used. Full 
growth media was used as a positive control, while serum free media was used as a 
negative control. Images of the wells were taken using an inverted microscope (Nikon 
Eclipse Ti2) after 0h and 12h of incubation. Pictures were analyzed using ImageJ to 
determine the overall gap closure, as previously described 57. 
Statistical Analysis.  
All samples were evaluated in triplicates. Data were analyzed using single-factor 
analysis of variance followed by Tukey’s Multiple Comparison Test assuming normal 
data distribution with a confidence of 95% ( p<0.05). 
 
 
Results and Discussion 
Formation of Calcium Deficient Hydroxyapatite Microparticles (CDHAp). 
The first aim of this chapter was to develop microparticles and characterize their size, 
chemical properties and Ca/P ratio to validate the formation of hydroxyapatite. 




and sodium dodecyl sulfate were used as a surfactant to form hollow calcium carbonate 
(CaCO3) template. HA was then formed by an anion exchange between CaCO3 and 
disodium phosphate dodecahydrate (Na2HPO4, 12H2O) under constant stirring 
(Figure 1a).  
Microparticles were measured to have an average diameter of 8.08 µm ± 2.68 µm, with 
96.35% of particles being between 5 µm and 20 µm (Figure 1b). SEM images of the 
particles (Figure 1c) show that homogeneous crystalloids were obtained. Commercially 
available particles (SBp) were also analyzed and were 73.8 nm ± 15.6 nm in diameter. 
Some broken microparticles can be observed revealing a hollow interior. HAp particles, 
unlike SBp, had a coarse surface, constructed by short needle nanoparticles (276nm by 
20nm), creating numerous interstitial spaces, or mesopores, which is believed to 
improve the absorption of growth factors.  The XRD patterns of the microparticles are 
presented in Figure 1d. The diffraction peaks at 25.8°, 28.9°, 31.7°, 32.8°, 34.0°, 39.1°, 
46.7°, 49.4°, and 53.2° are consistent with those of hydroxyapatite, confirming the 
fabrication of hydroxyapatite particles.  
XPS spectrum of the HA microparticles (Figure 1e) matched previously reported 





Figure 1: Hydroxyapatite Particles Characterization. (a) Hydroxyapatite particles (HAp) were synthesized in a 
two-step reaction. Aspartic acid and sodium dodecyl sulfate were used as surfactant to form hollow calcium 
carbonate (CaCO3) template. HA was then form by an anion exchange between CaCO3 and disodium 
phosphate dodecahydrate (Na2HPO4, 12H2O) under constant stirring (b) Particles size distribution. Average 
diameter is 8.08 µm ± 2.68 µm. 96.35% of particles’ diameter is with the range of 5-20 µm. (c) SEM images of 
the particles show that homogeneous crystalloids were obtained. HAp particles, unlike SBp, had a coarse 
surfaces, constructed by short needle nanoparticles creating numerous interstitial spaces (d) XRD patterns of 
the synthesized microparticles and hydroxyapatite (PDF 01-070-4465). (e) XPS spectrum of the HA 
microparticles matched previously reported hydroxyapatite XPS spectrum. Besides the expected Ca, P, and O 




peak was observed. Carbonate is a common impurity found incorporated into various 
synthetic calcium phosphates during synthesis, due to the presence of CO2 in the air 
and solutions. The Ca/P values were calculated directly from XPS data and were on 
average 1.36 ± 0.08. Stoichiometric hydroxyapatite has a Ca/P ration of 1.67, indicating 
that the HAp are calcium deficient. Bone is actually constituted of nano-crystalline, 
non-stoichiometric, calcium-deficient apatites whose Ca/P molar ratio can go from 1.33 
up to 1.67 59. Calcium-deficient hydroxyapatite (CDHA) appears biologically more 
active than HA. Structurally and physically, they are unstable and very reactive  due to 
a lower Ca/P ratio hence a higher solubility 60. Several hydroxyapatite parameters can 
affect the cellular activity: its composition, dissolution, topography and surface energy. 
For example, a clear link between dissolution rate and early bone formation in vivo and 
the osteogenic differentiation in vitro of osteoprogenitor cells has been demonstrated, 
suggesting the influence of free calcium and inorganic phosphates on bone formation 
61. Osteoblasts have also be shown to be sensitive to the crystal shape: large apatite 
crystals induced more bone sialoprotein and osteocalcin expression after 3 weeks of 
culture than small apatite crystals 62. This would suggest that the CDHA particles, 
whose composition and structure are very close to the natural bone mineral, could be 
of greater biological interest than stoichiometric, commercially available HA and a 
suitable candidate for bone regeneration 63,64.  
 Finally, HAp was suspended, alongside MSCs in a collagen gel, and co-cultured 
for 24h. Gels containing cells but no HA were used as a control. Brightfield images of 
the gels (Figure 2b.) showed that while HAp seemed well uniformly distributed 




viability stain was performed on the scaffolds at the end of the culture period (Figure 
2a), where green represents viable cells and red stains dead cells. The image displays 
high cell viability after encapsulation of the cells and microparticles in scaffolds. 






Figure 2: Hydroxyapatite Particles Characterization (2). (a) Cell viability after 24h of culture with either HAp or 
SBp. Green represents viable cells and red stains dead cells. The image displays high cell viability after 
encapsulation of the cells and microparticles in scaffolds. (b) Brightfield images of the gels showed that while HAp 




Osteogenic Potential of Calcium Deficient Hydroxyapatite Microparticles. 
MSCs are the most commonly used stem cells because of their beneficial properties: 
they are easily accessible, easily expandable, have a stable phenotype and respond 
appropriately to the bioactive factors with subsequent production of the typical 
osteogenic markers 65. Osteoblastic differentiation of hMSCs encapsulated in collagen 
with either CDHAp or SBp was assessed and compared to that of hMSCs in pure 
collagen to determine the effect of the microparticles.  
After 14 days of in vitro culture, cells were retrieved and DNA was collected. The DNA 
quantification assay showed no significant difference between groups at day 0 
(p=0.997). After 14 days of culture in osteogenic media, a significantly lower (p<0.05) 
DNA concentration in the samples containing CDHAp compared to the samples 
containing SBp or no HA (Figure 3a) was found. However, XTT results (normalized to 
DNA content) showed a significantly increased metabolic activity at D14 (p<0.05) ) 
for the cells cultured with CDHAp when compared to the two other groups (Figure 3b). 
These results could suggest that hMSCs cultured with CDHAp are less proliferative 
but more differentiated than hMSCs grown with SBp. Research suggests that 
proliferation and differentiation show an inverse relationship: differentiation usually 
coincides with proliferation arrest 66,67. In addition, Shum et al. demonstrated that 
metabolic activity is increased during osteogenic differentiation of MSCs 68. Active 
oxidative phosphorylation is likely required to meet high ATP demands needed for 
extensive biosynthesis of extracellular matrix protein during osteogenesis. 
mRNA expression of BMP2 and OCN was also used to monitor osteogenic 




MSCs cultured with both HAp (CDHAp and SBp) after 14 days (Figure 3c). A 
significant increase in fold change (p<0.05) in mRNA of both osteogenic markers was 
observed in the CDHAp group. Both BMP2 and OCN was described as a late marker 
of developing osteoblasts appearing with matrix mineralization and was at its 
maximum expression after 21 days post osteogenic induction 69. Therefore it would 
appear that MSCs grown with CDHAp are at a later stage of osteogenesis.  
During osteogenic differentiation, hMSCs will increase their deposition of minerals in 
the extracellular matrix (ECM). Therefore, Von Kossa staining was performed to study 
the mineralization and calcification of the collagen scaffolds, indicative of the stage of 
osteoblastic differentiation. Cross-sectional images of collagen scaffolds cultivated 
until day 14 and stained with Von Kossa are shown in Figure 3d. Mineralization, seen 
in dark brown/black, was minimal in no HA culture groups on day 14 and appeared the 
most intense in CDHAp groups.  
Using evidence from cellular metabolic activity and gene expression results as well as 
Von Kossa staining, we can conclude that overall, the coculture of hMSCs with 
CDHAp resulted in greater osteogenic differentiation, compared to control and SBp. 
Additionally, this suggests that calcium deficient hydroxyapatite is more biologically 







Figure 3: Osteogenic Potential of CDHAp. Ct: control group, HAp: 2ml/ml CDHAp and SB: 2mg/ml commercially available 
HA (Sigma). (a) After 14 days of culture in osteogenic media, a significantly lower (p<0.05) DNA concentration in the 
samples containing CDHAp compared to the samples containing SBp or no HA (b) Metabolic activity of cells after o and 
14 days of culture. The results are normalized to DNA content. Results showed a significant increase in metabolic activity 
at D14 in the CDHAp group. (c)  mRNA fold change for BMP2 and OCN after 7 and 14 days of culture. Rt-PCR showed an 
increase in gene expression of BMP2 and OCN in MSCs cultured with both HAp (CDHAp and SBp) after 14 days (d) Von 





VEGF Encapsulation and Bioactivity of CDHAp 
Synthesized calcium deficient hydroxyapatite particles have the potential to be 
employed as a drug vehicle with high drug loading and efficiency. To demonstrate 
these advantages, the drug loading and release capabilities of CDHAp have been 
evaluated. Figure 4a summarizes the drug loading efficiency of both CDHAP and SBp. 
The CDHAp showed a high VEGF loading efficiency of 64.88 % ± 4.82 %, which was 
significantly higher than the loading efficiency of SBp. This suggests that the inner 
hollow space and the mesoporous structures at the surface of CDHAp plays an 
important role in improving the specific surface area and therefore enhancing the 
loading efficiency. Because the initial concentration was considerably high, VEGF was 
most likely primarily absorbed onto HAp surface through ionic affinity and then were 
able to pass through the channels between needle-like nanoparticles and into the hollow 
space serving as a reservoir.   
A release study of the encapsulated VEGF into PBS was performed to evaluate the 
sustained release of growth factors from the microparticles. A burst of about 40% (1557 
pg/ml) of VEGF from CDHAp was observed during the first 24h, followed by a more 
gradual and linear release over the following 14 days, during which 88% (3425 pg/ml) 
of the entire amount of VEGF was released. Under the same condition, 80% VEGF 
(814 pg/ml) was release from SBp after 24h, and about 93% (946 pg/ml) of the initial 
VEGF concentration was released after 14 days. Compared to SBp, CDHAp hollow 
core could also play an important role in reducing the drug release and assuaging the 
initial burst release of VEGF. The hollow interior could serve as a drug reservoir, 




SBp, the trend observed was that CDHAp released their cargo much slower than SBp, 
which prolong the drug's effect. One day after the beginning of the release study, 
CDHAp had release significantly (p<0.05) less VEGF than SBp: 41.2% of total 
encapsulated VEGF for CDHAp versus 86.1% for SBp. 
 The angiogenic potential of CDHAp was assessed and compared to that of SBp. 
HUVECs were suspended in collagen gels, along with either SBp or CDHAp. Both 
microparticles were loading with VEGF. No HA particles were used as a control. After 
7 days of in vitro culture, cells were retrieved from the scaffolds and DNA was 
collected. The DNA quantification assay showed no significant difference between 
groups at day 0 (p=0.185). After 7 days of culture, a significantly higher DNA 
concentration (p<0.05) was found in the samples containing CDHAp compared to the 
samples containing SBp (Figure 4b). Similarly, XTT results (normalized to DNA 
content) showed a significantly increased metabolic activity at D7 (p<0.05) for the cells 
cultured with CDHAp when compared to the two other groups (Figure 4c).  
mRNA expression of PECAM and VEGF was also used to monitor angiogenesis. Rt-
PCR showed an increase in gene expression of both PECAM and VEGF in HUVECs 
cultured with both HAp (CDHAp and SBp) after 7 days (Figure 4d). A significant 
increase in fold change in mRNA (p<0.05) of both osteogenic markers was observed 
in the CDHAp group.  A set of experiments was conducted to investigate the ability of 
VEGF-CDHAp to stimulate the migration of HUVECs (Figure 4e). HUVEC migratory 
activity when cultured with CDHAp increased when compared to SBp. Quantification 
of the invaded area indicated that wound closure was significantly higher when 




these results indicate the superior ability of CDHAp loaded with VEGF to promote 
angiogenesis. 
Conclusion 
In the present study, we demonstrated the successful fabrication of calcium deficient 
hydroxyapatite microparticles, with biological properties closer to bone than 
stoichiometric, commercially available hydroxyapatite. These CDHA particles exhibit 
a well-defined 3D network of crystalline nanoplates forming mesoporous and hollow 
structures. The high specific area created by those structures enabled the loading of 
VEGF with high efficiency when compared to the loading efficiency of SBp. The high 
loading efficiency of VEGF and its sustained release property suggest that the HCHAs 
have the great potentials for bone-implantable drug-delivery applications. Furthermore, 
their biological performances were evaluated in vitro. Our results indicate that VEGF-
CDHAp can be used to improve both osteogenesis and angiogenesis, as evidenced by 
upregulation of osteogenic and vasculogenic genes, and an increase in matrix 
mineralization. The system developed in this study could be used to deliver not only 
VEGF but multiple bioactive growth factors and could find broad utility in many bone 
tissue engineering applications where sustained release of factors in a local 










Figure 4: VEGF Release and CDHAp Bioactivity. Ct: control group, Hap: HA: 2ml/ml CDHAp and SB: 2mg/ml store 
bought HA (Sigma). (a) Release profile of VEGF from SBp and CDHAp. The insert in the first graph shows the first 
24h of release. The table summarize the loading efficiency for both particles. (b) DNA quantification after 0 and 7 
days of culture. After 7 days of culture, a significantly higher DNA concentration was found in the samples 
containing CDHAp compared to the samples containing SBp (c) XTT results (normalized to DNA content) showed a 
significantly increased metabolic activity at D7 for the cells cultured with CDHAp when compared to the two other 
groups (d) mRNA expression of PECAM and VEGF was also used to monitor angiogenesis. Rt-PCR showed an 
increase in gene expression of both PECAM and VEGF in HUVECs cultured with both HAp (CDHAp and SBp) after 7 
days. A significant increase in fold change in mRNA of both osteogenic markers was observed in the CDHAp group.  
(e) Migration assay. Quantification of invaded area indicated that wound closure was significantly higher when 










Bone tissue engineering has emerged as a promising technique to fabricate 
biological substitutes 70.  Cells play a central role in bone regeneration; non-tissue, 
acellular materials will lack the abilities of resorption, secretion, and mineralization.  
Cellular strategies in bone tissue engineering play an important role, and proof of 
concept models have been previously demonstrated 71–78.  However, cells require 
mechanical support and a physical template, or scaffold to facilitate their attachment 
and to stimulate neotissue formation.  Such scaffolds should mimic the native ECM.  
Mechanical strength and architecture are important scaffold parameters; high 
interconnectivity between pores enabling nutriment and oxygen transport as well as 
pores size of at least 300µm have been showing to enhance bone formation and 
vascularization 79–81.  Porous bone scaffolds have been made using different techniques, 
such as particle/salt leaching 82, gas foaming 83, freeze drying 84, and phase separation 
85.  However, those approaches cannot allow full control over the pore size, porosity, 
interconnectivity, and specific shape of the scaffold.  Addressing those limitations, 
additive manufacturing (AM) has emerged in recent years as a promising method for 
the fabrication of porous scaffolds, providing accurate and precise architecture.  The 
                                                 
1 Adapted from CM Piard, Y Chen, JP Fisher, “Cell-laden 3d printed scaffolds for bone tissue 




first example of AM, called stereolithography, was introduced in 1986 by Chuck Hull 
and involved thin layers of material sequentially printed and cured with ultraviolet light 
to form a solid structure.  Currently, several other 3D printing approaches are used to 
fabricate scaffolds directly from a computer-aided design file (CAD), such as rapid 
prototyping and solid freeform fabrication, allowing scaffold 86.  Taking AM 
technologies a step further, bioprinting allows the direct and precise deposition, layer 
by layer, of biological materials, cells, and biochemicals.  Several technologies are been 
developed to fabricate 3D functional living structures, including inkjet bioprinting, 
microextrusion, and laser-assisted printing 87.  3D porous bone scaffolds fabrication 
has developed and investigated, both by standard AM approaches and by 3D 
bioprinting, as shown in Table 1 88,89,98,90–97. 
In bone tissue engineering, the presence of viable cells inside a graft has been shown 
to enhance bone formation in vivo, as cells not only participate in ECM formation but 
also stimulate bone remodeling using paracrine signals 99,100.  Cells are typically 
incorporated into AM fabricated constructs using one of two different strategies, as 
described in .  The first strategy, 3D bioprinting, involves the layer by layer deposition 
of a bioink, made of a scaffold material and cells.  The second strategy focuses on the 
fabrication of a scaffold by printing an acellular material, following by a post-treatment 
to remove cytotoxic crosslinking agents and to sterilize the scaffolds before seeding 
living cells.  Here, we review both approaches, focusing on fabrication techniques and 
scaffold materials.  Then we will describe and discuss the properties of the resulting 
constructs in term of mechanical properties, ECM production, and mineralization, and 





3D Bioprinting of Cell-Laden Hydrogels 
3D Bioprinting Techniques 
The main technologies used in 3D printing are inkjet and microextrusion 87.  Bone 3D 
printing is mostly extrusion-based 89–95.  This approach uses a three-axis dispensing 
system, which builds 3D constructs by extruding fibers of cell-laden biomaterials in a 
layer-by-layer fashion, as directed by CAD software.  The most common method to 
extrude fibers is by applying pressure from a compressed gas.  The construct, if 
necessary, is chemically or UV-crosslinked to maintain the structural integrity of the 
fibers.  The main advantage of microextrusion is the ability to deposit very high cell 
densities.  Inkjet printing has also been adapted to printing bone grafts 88.  This 
technology relies on the ejection of drops of liquid onto a substrate due to thermal or 
acoustic forces.  It provides excellent printing resolution, with controlled volumes of 
liquid being delivered to predefined locations. 
Cell viability after undergoing microextrusion has been shown to be lower than when 
using an inkjet printer.  Several dispensing parameters impact cell viability such as the 
extrusion pressure, the dispensing nozzle diameter, and length, and the nozzle head 
speed.  Among those parameters, the extrusion pressure has been shown to have the 
most significant effect on cell viability 101.  Cell survival rates using microextrusion 
range from 40 to 86%, and decrease as the extrusion pressure increases, a phenomenon 
likely due to shear stress 101,102.  Cell viability is important as cell must be not only alive 




However, it has been shown that initial cell damages due to printing may be reversible 
with time 102. 
One of the most significant challenges with 3D bioprinting is determining the 
appropriate material that will provide the right structural and mechanical properties for 
a bone graft.  This material, in addition to being biocompatible and biodegradable, must 
protect the cells from damage during printing and allow them to proliferate, 
differentiate, and produce their own ECM post-printing.  The material must also be 
suitable for the printing techniques described above, with suitable crosslinking 
mechanisms to facilitate the printing process and the controlled and precise deposition 
of the cells. 
Hydrogels are highly hydrated materials composed of hydrophilic polymers that are 
crosslinked to form three-dimensional networks 103.  They are popular materials for 
bioprinting, as they are able to undergo a phase transition from liquid to gel based on 
thermal or chemical cues 104.  Their structure is morphologically similar to that of 
natural ECM due to their high water content, and they have shown excellent 
biocompatibility and biodegradability 105.  Hydrogels are widely used to encapsulate 
cells, enabling them to exhibit phenotypes more similar to those in vivo than when the 
cells are grown in monolayer culture 106,107.  Currently, the main hydrogel materials 
used in 3D bioprinting for bone tissue engineering are based on natural polymers such 
as alginate and gelatin, or synthetic molecules such as poly(ethylene glycol) (PEG).  






Printing With Naturally Derived Polymers 
Alginate remains one of the most widely used natural materials for cell-based hydrogel 
printing of bone substitute 108–110.  It is a polysaccharide, a polyanionic linear block 
copolymer containing blocks of (1,4)-linked β-D-mannuronic (M block) and α-L-
guluronic (G block) acids.  When dissolved in an aqueous medium, alginate forms a 
hydrocolloid, which gels under gentle conditions induced by multivalent cations, such 
as Ca++, and therefore the hydrogel is characterized by excellent cells compatibility 111.  
Alginate is characterized by a wide pore size distribution (5–200 nm), explaining an 
important diffusion rate of large molecules in and out of the gel 111.  Alginate has also 
demonstrated the capacity to support cellular function and differentiation in vitro, 
including bone formation 112–115. 
One of the main problems with printing alginate is overcoming its low viscosity. A low 
viscosity usually leads to the collapse of deposited structures during printing,  and 
directly influences shape fidelity post printing 116. Increasing alginate concentration is 
a common approach to improve its printability 117.  Another approach is to use a 
combination of alginate with a second biopolymer during scaffold fabrication.  The 
addition of gelatin can enable fast solidification of the 3D structure, as it acts as a short-
term stabilizer. Gelatin is composed of acid-denatured collagen, the main component 
of native ECM. Due to its biocompatibility and rapid biodegradability, it has been used 
for drug release and tissue engineering due 118,119.  Gelatin gelation is solely based on 
physical intermolecular interaction of the gelatin molecules and the resulting gels are 




methacrylate (GelMA) is a photocurable material and can be used as a bioink in 3D 
bioprinting 120,121.  Schütz et al. used methylcellulose, a water-soluble derivative of 
cellulose, in combination with alginate to form a viscous solution in water 93.  
Methylcellulose does not contribute to the gelation and is released from the printed 
construct after crosslinking.  Long-term stability is provided by the alginate, and the 
loss of the second polymer has no impact on geometry, nor does it increase the 
scaffold’s microporosity 94,122.  To this end, porosity has been shown to substantially 
impact scaffold mechanical properties 79. 
In addition to understanding the viscosity and flow properties of the material, 
mechanical properties of the scaffold must be considered; in general, hydrogels are too 
soft for load-bearing defects 123.  Alternative strategies to enhance their biological and 
mechanical properties have been developed for printing composite biomaterials by 
combining stiff materials with mechanically-weak hydrogels, or by suspending 
particles with bioactive potential into the hydrogel matrix.  Wang et al. showed that a 
cell-laden alginate/collagen matrix could be supplemented with particles of bioglass, a 
well-established, hard, porous material used in the fabrication of bone replacement 
scaffolds 124,125, in order to render the material stiffer and stimulate cell growth and 
mineralization 91.  Microcarriers (MCs) are particles that promote attachment, homing, 
and survival of cells, and their encapsulation in hydrogel matrices has been shown to 
increase the mechanical strength of the gel 126127.  Osteoblasts cultured on MCs have 
been found to better retain their phenotype and display greater potential to regenerate 
bone 128.  Levato et al. incorporated MCs in GelMA bioink and showed that not only 




MCs, but also differentiation of hMSCs improved 92.  Wüst et al. used a combination 
of gelatin, alginate, and hydroxyapatite (HA) to improve the mechanical stiffness of 
the hydrogel 94.  HA has been shown to be osteoconductive and enhance cell 
attachment, guiding osteogenic differentiation in vivo 108,129. 
 
Bioprinting With Synthetic Polymers 
However, even composite hydrogels based on natural polymers still have low stiffness 
(in kPa range) when compared to bone (in the GPa range) (Table 1).  Greater stiffness 
can be achieved by using synthetic polymers and molecules.  Gao et al. used PEG-
GelMA hydrogels for inkjet printing of bone constructs 88.  They showed improved 
mechanical properties compared to GelMA-only scaffolds, with a reported modulus of 
1-2 MPa.  Poly(L-lactic-co-glycolic acid) (PLGA)-PEG-PLGA hydrogels have also 
been used to print scaffolds 95.  In this case, even greater stiffness was achieved, with a 
modulus between 54.4 and 57.3 MPa; while this is within the range of cancellous bone, 
it is still lower than moduli obtained in other bone tissue engineering studies.  Synthetic 
polymers are the most commonly used polymers for 3D printing in bone tissue 
engineering.  However, harsher conditions, such as exposure to extreme temperature, 
pressure, or pH, are usually involved in the printing process, and the direct 
incorporation of cells is generally avoided 130,131.  In this scenario, the cells are seeded 





Cell Seeding on 3D Printed Scaffolds 
Rapid Prototyping Techniques for Scaffold Fabrication 
Layer-by-layer scaffold fabrication techniques based on rapid prototyping methods 
include stereolithography (SLA) 132, 3D printing (also called melt plotting) 133, selective 
laser sintering (SLS) 134, fused deposition modeling (FDM) 135 and direct writing 136.  
With SLA, scaffolds are formed by immersing a platform in a liquid polymer.  
Exposure to focused light, according to a desired design, crosslinks and solidifies the 
polymer at the focal point.  As the platform moves upward or downward, the scaffold 
is created.  The same principle is applied to SLS, where powders are added and sintered 
using a laser source.  3D printing, FDM, and direct writing involve layer-by-layer 
extrusion at a constant rate and under a specific pressure. 3D printing is based on the 
deposition of strands of viscous material in solution, while FDM uses heated 
polymers/ceramics, and direct writing uses liquids. In direct writing, the solidification 
of the scaffold is achieved through a liquid-to-gel transition.  These techniques present 
advantages and disadvantages, as discussed extensively in previous reviews 86.  Briefly, 
3D printing, due to mild processing conditions, allows the incorporation of 
biomolecules and drugs, but it is still limited by the post-processing methods required 
for some materials.  As SLA requires the use of focused light, only photopolymers can 
be used; however complex internal features can be obtained.  With SLS, no post-
processing is needed, but the resolution of scaffold features depends on the diameter of 
the laser used.  Direct writing enables a precise control on thickness.  SLS, FDM, and 
direct writing do not require a supportive platform.  Depending on scaffold composition 




solidification mechanism, and solution homogeneity – a specific technique may be 
more amenable than others when printing scaffolds for bone tissue engineering. 
 
Ceramics And Polymers 
A broad range of ceramics (calcium phosphates 137,138 or bioactive glass 139), polymers 
(poly(ɛ-caprolactone) (PCL) 140,141), or composite materials 142,143 have been 
successfully used for 3D printing.  Ceramics are the gold standard for repairing bone 
voids, as they have good biocompatibility and have been shown to be osteoconductive 
144.  Ceramics include calcium phosphates, bioactive glass, and bioactive compounds 
of glass and ceramic 145.  Calcium phosphates, like biodegradable tricalcium phosphates 
(TCP) and hydroxyapatite (HA), are among the most studied ceramic materials 144.  Due 
to the formation of iron-rich cellular microenvironment, ceramics have the ability to 
upregulate osteogenesis. Moreover, their degradation rate has been shown to be lower 
than hydrogels, allowing for prolonged structural support and guided neotissue 
formation 130.  SLS is commonly used for ceramics 3D printing.  Scaffolds with a high 
HA content, superior to 50% w/v, have been successfully fabricated 146.  The effect of 
pores size on osteoblasts was studied on 3D printed TCP scaffolds, showing that a 
decrease in pore size from 1000 to 750µm resulted in an increase in cell density and 
proliferation 147.  TCP 3D printed scaffold have also been shown to promote 
osteogenesis in a rat femur model 148.  
Polymers represent other promising materials for bone tissue repair as they provide 




tunable degradation characteristics 149.  The polymers most commonly used for 3D 
printed bone scaffolds include PCL, poly(lactic acid) (PLA) 150, poly(glycolic acid) 
(PGA) and its co-polymer poly(lactic-co-glycolic acid)(PLGA) 98, poly(methyl 
methacrylate) (PMMA), polyethylene (PE) 151, and poly(propylene fumarate) (PPF) 152. 
FDM techniques have been used to fabricate PCL scaffolds 153,154.  Reichert et al. 
printed a composite material made of PCL and 20% w/v of TCP, extruding filament of 
300 µm diameter forming scaffolds with a 70% porosity and an elastic modulus of 22.2 
MPa 154.  In vivo implantation showed a significantly greater bone formation and 
mechanical strength when compared to the gold standard, autologous grafts.  Wang et 
al. fabricated PPF scaffolds using SLA and showed that their compressive modulus 
was in the range of bone and that they provided mechanical stability while degrading 
without inducing any cytotoxic response 155.   
As with hydrogels, these polymers have also been paired with bioactive molecules in 
order to improve scaffold mechanical or biological properties.  Furthermore, molecule 
release and surface properties of the material play an important role in stimulating cell 
interaction, differentiation, and infiltration throughout the 3D printed bone scaffold 156.  
Lee et al. used stereolithographic PPF scaffold as a delivery vehicle for PLGA 
microspheres containing BMP-2 157.  They were able to fabricate scaffolds that 
maintained an interconnected network of pores and showed improved cell 
differentiation in vitro.  Gonçalves et al. used carbon nanotubes (CNTs) in combination 
with PCL-HA scaffolds in order to achieve polarized and conductive surface properties 




that cell adhesion and proliferation was improved in CNT scaffolds due to the 
formation of an apatite layer on the surface. 
 
Cell-Biomaterial Interactions 
Another important point to consider when seeding cells on a 3D printed scaffold are 
the cell-biomaterial interaction, which plays an important role in the growth and 
differentiation of cells on the scaffold’s surface 156.  Surface properties of scaffolds can 
be tuned to improve cell adhesion, proliferation, and differentiation after its attachment 
on the surface 159,160.  Different methods, such as physical adsorption or covalent 
conjugation, have been investigated to modify scaffold surfaces.  For example, PCL 
surface characteristics are not favorable for cell adhesion and proliferation, as it is a 
hydrophobic polymer and lacks a bioactive functional group 161.  Seydnejad et al. 
developed a modified PCL, poly(hydroxymethylglycolide-co-caprolactone), to 
increase its hydrophilicity and allow tuning of the degradation rate and hydroxyl groups 
to enable surface functionalization with peptides 133.  Their results showed that 
metabolic activity of the cells was significantly enhanced, and cells differentiated 
toward osteogenic lineage when compared with PCL scaffolds.  Kao et al. 3D printed 
PLA scaffolds and used a surface coating of poly(dopamine) (PDA), which, due to 
amine functional groups, has the ability to attach to various hydrophobic surfaces via 
self-polymerization to improve cell attachment and differentiation 162.  An increase in 
cell adhesion and proliferation was observed, due to improved surface hydrophobicity, 
when compared to unmodified PLA scaffolds.  More osteogenic differentiation, as well 




with type I collagen and were able to improve MSC adhesion and viability on 
PLGA/chitosan scaffolds, as well as direct differentiation towards osteoblastic lineages 
163. 
Once the cell-based construct is fabricated, either a cell-laden printed hydrogel or a 
scaffold seeded, it needs to either be implanted in vivo or pre-cultured in vitro.  
However, the 2D in vitro culture of a 3D construct presents some hurdles.  The cells 
within the construct receive a limited amount of glucose, nutrients and oxygen, which 
results in cells death 164.  In response to this problem, bioreactors systems have been 
developed to optimize in vitro culture.  It has been demonstrated that bioreactor, in 
particular, perfusion system, effectively perfuse media throughout a porous 3D 
construct and enhance nutrients transport 165.  By exposing the cells to fluid shear stress, 
bioreactors have even been shown to improve upregulate the expression of osteoblastic 
markers and mineralization of the ECM 166. 
 
3D Bioprinting vs Cell Seeding on a Printed Scaffold 
Cell-laden 3D printing scaffolds present several advantageous proprieties when 
compared to standard fabrication techniques.  Their use enables precise positioning of 
cells and biomaterials, tunable mechanical properties, fine control of the external and 
internal architecture.  Moreover, it allows for scalable and patient-specific fabrication 
of complex designs.  However, both approaches using cells alongside 3D printing 
described previously are unable to satisfy all those criteria at once. Each technique has 






When comparing cell printing versus cell seeding post-printing, the resulting 
mechanical integrity and compressive modulus of the printed construct are different.  
For example, hydrogels are mainly used for cell printing but have lower mechanical 
strength than printed polymer and ceramic scaffolds.  3D bioprinted constructs, based 
mostly on hydrogels, have a very low stiffness (in kPa range) when compared to bone, 
even after improvement of the materials as described previously.  In addition, it is 
known that crosslinked alginate loses its mechanical integrity over time due to an 
outward flux of ions 167.  Compared to native tissue, the compressive modulus of 
cancellous bone is approximately 244 MPa, while that of cortical bone is a degree of 
magnitude lower – about 17 MPa 168,169.  It has been shown that cells can act as a 
reinforcing material to hydrogels; as they differentiate, and mineralization of the ECM 
appears, the modulus of the gel can increase by up to 100% 88,92.  Even in this case, the 
stiffness is still too low to match that of bone.  However, the use of synthetic polymers 
and rapid prototyping enables the fabrication of scaffolds with compressive modulus 
from 4-77.2 MPa (Table 1), which is in the range of cancellous bone.  The higher values 
in this range could, however, be related to the scaffold porosity as it is directly 
connected to mechanical strength 170.  Finally, in particular cases of non-load bearing 
defects, mechanical properties may not be the main concern, as it might not be 
necessary to provide implants with the original biomechanical properties of bone since 





Macro- and Microporosity 
One of the main challenges in the fabrication of a cell-laden hydrogel scaffold is the 
generation of 3D constructs with relevant size and of high accuracy with respect to the 
predefined shape, porosity, and inner pore structure.  On the contrary, when printing 
polymer or ceramic scaffolds prior to cell seeding, complex internal features can be 
obtained with a good resolution due to the better structural integrity of the fibers or 
struts.  Pore size and porosity not only affects the mechanical characteristics of a 
scaffold but also cell behavior.  Tarafder et al. studied the effect of pore size on 
osteoblasts using sintered 3D printed tricalcium phosphate (TCP) scaffolds and showed 
that lower pore size resulted in an increase in cell density, good cell adherence, and cell 
ingrowth into the pores 147.  3D printed TCP samples with macro- and microporosity 
also facilitated osteogenesis in a rat femur 148.  In addition, the presence of micropores 
within macropore walls has been indicated as a method to make the material 
osteoinductive 171.  With the optimization of 3D bioprinting techniques, it may become 
possible to create pores in the appropriate range for supporting bone tissue regeneration 
in vitro and in vivo. 
 
Cell Distribution and Integration Within the 3D Printed Scaffold 
3D bioprinting of cell-laden hydrogels may not exhibit as intricate designs as scaffolds 
printed prior to cell seeding, but it allows control of cell distribution and cell density 
within the graft by incorporating cells directly in the printed material.  Among other 
hydrogel printing techniques, inkjet printing has the capacity to create a concentration 




scaffold 172.  3D bioprinting also enables the deposition of multiple cell types in the 
same construct.  Fedorovich et al. used this technique to improve the vascularization 
of a bone construct by printing two different hydrogels loaded with endothelial 
progenitor cells (EPCs) or MSCs.  After 6 weeks of implantation, they showed bone 
formation in cell-laden gels, as well as tubular structures and erythrocytes in some of 
the lumina 173.  The multiple printed cells retained their functionality and produced 
ECM according to their respective cell type.  While hydrogels expose cells to a highly 
hydrated 3D microenvironment that closely resembles the natural ECM 174, the 
majority of hydrogels used for 3D bioprinting only provide the cell with a non-
interactive encapsulation matrix, a template to permit cell localization but lacking any 
surface modification to promote cell attachment and migration 103.  Strategies to seed 
cells rather than embed them provide an alternative to more freely promote cell motility 
in a bone scaffold.  Due to high temperatures or pressures, rapid prototyping techniques 
for printing polymers and ceramics do not allow the exact deposition of cells in the 
scaffold.  As a result, cells that are then seeded on the porous scaffold often remain on 
its periphery.  The promotion of cell migration to the center of the scaffold may then 
rely on other external cues, such as surface modification, signaling from bioactive 
molecules, or even flow perfusion 165. 
One of hydrogels other advantages is the ability to expose cells to a highly hydrated 
3D microenvironment that closely resemble the natural ECM 174.  However, the 
majority of hydrogel for 3D bioprinting only provide the cell with non-interactive 
encapsulation matrix, acting as a template to permit cell localization but lack of any 





Two techniques for bioprinting and incorporating cells have been highlighted for bone 
tissue engineering: 1) 3D bioprinting of cell-laden hydrogels, and 2) seeding cells onto 
3D printed polymeric or ceramic scaffolds.  While direct embedding of the cells during 
scaffold fabrication can lead to a high seeding density, uniform distribution, and spatial 
control of one or more cell types, the materials used – mostly hydrogel-based – do not 
allow for an exact and intricate design of the scaffold, as in the approach of printing 
and processing a polymer or ceramic-based scaffold prior to seeding.  Another major 
problem discussed above is the lack of mechanical integrity.  Even though hydrogel 
modifications can improve the compressive strength of scaffolds, moduli are still low.  
The other option, seeding cells on a 3D printed scaffold, allows the use of more stiff 
polymeric or ceramic materials with mechanical properties in the range of those of 
cortical bone.  However, optimal seeding, adhesion, and proliferation of cells may 
require surface modification of the scaffolds.  Based on currently reported methods, no 
single fabrication technique is able to satisfy all the requirements discussed previously.  
Scaffold fabrication of bone implants would ideally require the use of two printable 
matrices: a solid, mechanically strong, porous matrix and a softer biocompatible 
hydrogel into which the embedded cells can proliferate and differentiate, printed 
together in an intricate design.  Furthermore, when designing a scaffold for bone tissue 
engineering, it is important to prioritize functionality over complexity.  Exploiting 
benefits from both techniques to promote cell viability and infiltration, mechanical 
integrity, and proper matrix remodeling of defect tissue will result in the most 




Table 1: Techniques Used For Inclusion Of Cells In Bone Scaffolds During Or After Printing.  Examples of studies 
involving both cells and 3D printing for the fabrication of bone grafts are provided.  The printing techniques, the 
type of cells used, the biomaterial printed, the results of mechanical testing and the stain used for histology of in 
vivo samples are summarized. MSCs: mesenchymal stem cells, EPCs: endothelial progenitor cells, PEG: polyethylene 
glycol, PLGA: poly(lactic-co-glycolic acid), HA: hydroxyapatite, PLLA: poly-L-lactic acid, PPF: poly(propylene 
fumarate, HE: hematoxylin and eosin, OCN: osteocalcin, ALP: alkaline phosphatase , COL1: collagen 1, vWF: von 















Inkjet Printing Human MSCs 
PEG / Gelatin 
Methacrylate 
35 kDa No [27] 
  Human MSCs Acrylated PEG 1 to 2 MPa No [38] 











  SaOS-2 cells, 
Alginate / Gelatin / 
Silica 
NA No [30] 
  Rat MSCs 
Gelatin Methacrylate 
/ Gellan Gum 
42 to 48 kPa No 92 
  Human MSCs 
Alginate / 
Methylcellulose 
101 kPa No 93 
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Figure 5: Strategies  For The Fabrication of Cell-laden 3D Printed Scaffolds. Cells are typically incorporated into 3D printed constructs using one of two 
different strategies. The first strategy, 3D bioprinting (A), involves the preparation of a bioink, a cell laden hydrogel (1 and 2), and its layer by layer 
deposition (3).  The second strategy (B) focuses on the fabrication of a scaffold by printing an acellular material (4), such as a synthetic polymer, before 








The use of in vitro coculture of human umbilical vein endothelial cells 
(HUVECs) and human mesenchymal stem cells (hMSCs) has been one of the most 
explored options to improve neovascularization of the graft [8, 11-12]. In cortical bone, 
both cell populations, osteogenic and vasculogenic, are arranged in a well-defined 
pattern, called osteons 175. Each osteon is composed of concentric bone-cells containing 
layers (lamellae) surrounding the Haversian canal, a narrow central channel, which 
contains small blood vessels. One attempt to recreate osteon-like structures used 
electrospun gelatin/PLLA rods seeded with osteoblasts 176. However, cell infiltration 
in these avascular scaffolds was hindered by the tight nanofibrous network resulting in 
cell apoptosis.  
To address this shortcoming, we present in this paper an alternative method to mimic 
the spatial pattern of HUVECs and hMSCs found in native osteons based on the use of 
extrusion-based 3D bioprinting (3DP). 3DP, as discussed in the previous chapter, offers 
an efficient tool for accurate fabrication of biomaterial scaffolds with tunable properties 
177. Fibrin is a natural polymer known to support wound healing by inducing 
angiogenesis and promoting cell attachment and proliferation, and therefore an 
                                                 
2 Adapted from CM Piard, H Baker, T Kamalitdinov and JP Fisher, “Bioprinted osteon-like scaffolds 




attractive matrix for stem cell differentiation and tissue engineering 178–180. Although 
fibrin has shown potential in vitro in promoting osteogenesis, it lacks the mechanical 
strength required for bone tissue engineering 181.  The co-printing of a solid 
mechanically strong and porous matrix, such as polycaprolactone (PCL) along a softer 
biocompatible hydrogel into which the embedded cells can proliferate and differentiate 
is an alternative strategy 182. PCL is biocompatible and exhibits a slow biodegradation 
rate that can maintain mechanical stability long enough to allow new bone formation 
183.  
In the present study, the overall objective was to develop a 3DP biphasic osteon-
like scaffold, containing two separate osteogenic and vasculogenic cell populations 
encapsulated in a fibrin bioink in order to improve neovascularization. To this end, the 
first objective was to optimize the fibrin bioink to improve the resolution of printed 
fibers and ensure a reproducible printing process; the influence of printing parameters 
on extruded fiber diameter and cell survival was also investigated. The second objective 
was to improve the mechanical strength of the construct by co-printing the fibrin bioink 
along a supporting PCL carrier scaffold.  Finally, HUVEC and hMSC laden fibrin 
hydrogels were printed in osteon-like patterns and cultured in vitro. Biphasic scaffolds 
seeded with rat aortic endothelial cells and MSCs were implanted subcutaneously in 
rats.  Results showcase the capacity of our 3DP biphasic construct to provide accurate 





Material and Methods 
Cell Culture 
L929 cells (ATCC, Manassas, VA) were cultured as per the manufacturer’s 
specifications with Minimum Essential Medium (Life Technologies, Frederick, MD) 
and 10% horse serum (Life Technologies).  Prior to printing, cells were passaged using 
Trypsin/EDTA and encapsulated in fibrin bioink (two densities were examined, 2x106 
cells/ml and 10x106 cells/ml). hMSCs (Lonza, Walkersville, MD) were cultured in 
control media consisting of Dulbecco's Modified Eagle's medium (DMEM, Gibco, 
Carlsbad, CA) supplemented with 10% fetal bovine serum (Gibco), 1.0% v/v 
penicillin/streptomycin (Gibco), 0.1 mM non-essential amino acids (Gibco), and 4 mM 
L-glutamine (Gibco as per the manufacturer's specifications). Cells were expanded on 
tissue culture polystyrene flasks with media changes every 3 days and grown to 80% 
confluency before being passaged using trypsin/EDTA. Cells at passage P2 were used 
for the experiments. HUVECs (Lonza) were cultured in EBM-2 Basal Medium (Lonza) 
supplemented by EGM-2 SingleQuot Kit.  Rat primary aortic endothelial cells 
(RAECs) were purchased from Cell Biologics (Chicago, IL) and cultured according to 
manufacturer instructions. Rat MSCs (rMSCs) were purchased from RD Systems 
(Minneapolis, MN) and cultured in osteogenic media for 7 days prior to implantation. 
The osteogenic media was formulated by supplementing growth media with 100 nM 
dexamethasone (Sigma, St. Louis, MO), 10 mM β-glycerophosphate (Sigma), and 173 
mM ascorbic acid (Sigma).  Cells were expanded on tissue culture polystyrene flasks 
with media changes every 3 days and grown to 80% confluency before being passaged 





Fibrin Hydrogel Preparation and Characterization 
Fibrinogen and thrombin from bovine plasma, and gelatin type I were purchased from 
Sigma. Type A porcine gelatin (300g Bloom) was purchased from Sigma. The bioink 
was prepared by mixing different ratios of fibrinogen and gelatin and heating to 60°C 
for 15 min. The hydrogel samples were printed using an extrusion-based bioprinter 
(3D-Bioplotter; EnvisionTEC; Germany). All printing supply (30cc barrel and 200 
µm/400 µm precision tips) were purchased from Nordson EFD (RI, USA). The fibrin 
bioink was loaded into the low-temperature printer head and allowed to equilibrate for 
30 min at a 22°C. Printed constructs were crosslinked in 100 U thrombin for 30 min. 
The printer took successive images of each layer during printing, allowing 
quantification of strand diameter in each layer.  
Swelling experiment:  For each bioink formulation, nine samples per group were 
printed and crosslinked. Each 10 mm by 10 mm sample was printed using a 200 µm 
tip, and fibers were spaced every 200 µm.  Pictures were taken before and after 24 h 
incubation in PBS at 37°C. Images were analyzed using ImageJ to calculate strand 
diameter and pore area. The swelling was calculated by dividing the average porosity 
of a sample post-printing by the average porosity of the same sample after incubation.  
Cell Viability Assay:  Mouse fibroblast, L929, was used to assess in vitro viability, as 
per ISO standard 10993-5. Cell viability was assessed using a Live/Dead assay 
(Invitrogen) following the manufacturer’s protocol. Briefly, 6 samples per group were 




was incubated in 70% methanol (Sigma) for 15 min prior to Live/dead staining. 
Fluorescent images were taken using a confocal microscope (Leica SP5 X). Five digital 
images per samples, with each an area of 1 mm2, were processed in ImageJ. A resulting 
percentage of cell viability was calculated from the ratio of the number of live cells 
divided by the total number of cells.  
Evaluation of Fibrin Hydrogels: Shear stress and viscosity measurements as a function 
of shear rate of the fibrin bioink were obtained at 22°C (printing temperature) using an 
AR2000 stress-controlled rheometer (TA Instruments, Newark, DE) with a plate-plate 
geometry. A Q800 Dynamic Mechanical Analyser (TA Instruments LLC, Delaware, 
USA) was used to evaluate the compressive modulus of fibrin hydrogels. The 
compressive stress-strain was obtained at a strain rate of 1mm/min at room temperature.   
PCL Carrier Scaffold Fabrication and Characterization 
Computational Modeling: Scaffolds were designed with 3D solid modeling CAD 
software (Solidworks 2015). Circular cross-sections were swept along a pattern 
mimicking the Bioplotter needle path during printing to make a uniformly porous 
structure. CAD models corresponding to various extruder needle sizes (200 and 400 
µm) and inner cylinder diameters (2, 4, and 6 mm) were designed. A computational 
fluid dynamic analysis was performed using Solidworks Flow Simulation Module. 
Briefly, the scaffold models were enclosed in a hollow cylinder to allow for the 
establishment of the computational domain with the inlet perfusing water at a fully 




the scaffold and the outlet representing environmental pressure at the top end of the 
scaffold.  
PCL Samples Preparation: Scaffolds, with a dimension of 10 mm in diameter and 5 or 
10 mm in height, were fabricated using a commercial 3DP system with corresponding 
cartridges and needles (3D Bioplotter, EnvisionTEC, Gladbeck, Germany). PCL (MW 
43000, Polysciences, Warrington, PA) was loaded into a high-temperature print head 
and heated at 120°C for 30 min prior to printing. Strands were extruded at a pressure 
of 5 bar and speed of 2 mm/s to form scaffolds.  
Scanning Electron Microscopy (SEM): For morphology observation of internal 
structures, samples were imaged by a field emission gun scanning electron microscope 
(Hitachi SU-70) at 5 kV. Images were analyzed using ImageJ to calculate pore size and 
strand diameter and to determine printing accuracy. 
Compressive Mechanical Testing: Compressive mechanical analysis was performed on 
four samples per group using an Instron mechanical testing system (33R/4465, 
Norwood, MA). All tests were performed using a high-capacity load cell (5000 N). 
Samples were compressed at a displacement rate of 2 mm/min, and experimental values 
were recorded every 10 ms. Compression was maintained until a drop of at least 60% 
in force was measured. Engineering stress and strain were calculated based on original 
cross-sectional area and height, respectively, which were then used to compute 
compressive modulus, 1% offset yield stress and ultimate compressive stress.  




Scaffolds Preparation: Scaffolds for in vitro and in vivo evaluation were fabricated 
using a commercial 3D printing system (3D Bioplotter, EnvisionTEC, Gladbeck, 
Germany). For both experiments, cells were passaged, suspended in media and 
centrifuged to form a pellet. After aspiration of the supernatant, the pellet was then 
suspended in fibrin bioink by manual pipetting, until the solution was homogenous and 
all clumps were broken down.  All fibrin samples, control and experimental, were about 
1 mm in thickness and 2.5 mm in diameter. For in vitro evaluation, fibrin bioink 
encapsulating either 2x106 hMSCs/mL or 3x106 HUVECs/mL were loaded into 
separate print heads and were heated to 22°C for 30 min prior to printing. Control 
groups consisted of fibrin bioink casted within the barrel of a 3 mm diameter syringe 
and contained a suspension of hMSCs and HUVECs (ratio 3:1) at a density of 2x106 
cells/mL. The ratio was calculated based on the actual volume of ECs and MSCs bio 
inks used by the Bioplotter to print the experimental samples (19µL and 73µL 
respectively, for a print, comprise of 25 osteons). Once gelled, control samples were 
casted out of the syringe using the plunger. All scaffolds were crosslinked into 100 U 
thrombin for 30 min before being transferred to appropriate culture media and 
incubated at 37°C. Media was changed every 2 days. For in vivo experiments, fibrin 
bioink encapsulating 2x106 rMSCs/ml or 3x106 RAECs/ml and PCL were loaded into 
separate print heads and were heated to 22°C and 120°C respectively, for 30 min prior 
to printing. Control groups consisted of printed PCL base and a casted fibrin bioink 
disc containing either a suspension of rMSCs or a suspension of rMSCs and RAECs 
(ratio 3:1) at a density of 2x106 cells/ml. All scaffolds were allowed to crosslink for 




DNA quantification Assay: Cell samples from each group (n=9) were isolated from 
fibrin hydrogels by dissolution in 1 mg/mL collagenase (Sigma) for 120 min at 37°C 
and a cell pellet was formed by centrifugation and washed with PBS three times. Total 
DNA was isolated using DNeasy Blood and Tissue Kit (Qiagen) according to the 
manufacturer instructions. DNA content was quantified using the PicoGreen DNA 
assay (Invitrogen) following the manufacturer's instructions. 
Quantitative reverse transcriptase polymerase chain reaction (rt-PCR): Total RNA was 
isolated using the RNeasy Plus Mini Kit (Qiagen), following the supplier’s protocol 
(n=9). Reverse transcription was performed using TaqMan Reverse Transcription 
reagents (Applied Biosystems) following the supplier’s protocol. qRT-PCR was 
performed using TaqMan PCR Master mix and TaqMan Gene Expression Assays for 
alkaline phosphatase (ALP), bone morphogenetic protein-2 (BMP2), vascular 
endothelial growth factor-A (VEGFA) and platelet and endothelial cell adhesion 
molecule-1 (PECAM1). Quantification of target gene expression was calculated 
relative to the reference glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene. 
The mean minimal cycle threshold values (Ct) were calculated from triplet reactions.  
Animal Implantation: The Institutional Animal Care and Use Committee of the 
University of Maryland approved the study (protocol number R-MAY-18-26), and all 
animals were treated in accordance with the Guide for the Care and Use of Laboratory 
Animals. The experiment was conducted in 6 male adult Sprague Dawley rats. A small 
incision was made on the back of each animal, and one scaffold from each group was 




euthanized and the samples and surrounding tissue were explanted. Each explanted 
tissue sample was preserved in paraformaldehyde (4%) for histological analysis. 
Histological Analysis: Explanted tissue samples were processed, embedded in paraffin 
and sliced (15 µm slides) by Histoserv, Inc. (Germantown, MD). For histological 
evaluation, sections were stained by Masson's Trichrome staining and Von Kossa 
staining, to demonstrate deposits of calcium or calcium salts. Von Kossa calcium 
positive control slides (placenta) were purchased from Newcomer Supply (Middleton, 
WI). Images were analyzed using ImageJ to quantify collagen surface area, cell surface 
area, and the number of blood vessels per area. Area refers here to the area of the 
picture, to which the empty area (void left by the PCL scaffold) were subtracted. To 
quantify the collagen surface area (stained blue) and cell surface area (stained purple), 
first hues were adjusted using the function Adjust/Color Threshold to isolate either 
blues or purples. The pictures were then made binary (Process/Binary), and the black 
surface area was measured. Cell or collagen surface area was obtained by subtracting 
the area occupied by the scaffolds fibers to the black surface area. Blood vessels were 
identified as a tubular structure with a dark purple rim, filled with erythrocytes (stain 
light purple/red). 
Statistical Analysis 
Data were analyzed using single factor analysis of variance (ANOVA) followed by 
Tukey’s Multiple Comparison Test assuming normal data distribution with a 





Results and Discussion 
3D Printed Fibrin Bioink 
3D printing offers an efficient tool for accurate fabrication of biomaterial scaffolds with 
tunable properties and defined architecture. The first objective of this work was to 
optimize the fibrin bioink to improve the resolution of printed fibers and to understand 
the influence of printing parameters on extruded fiber diameter and cell survival in 
order to ensure a reproducible printing process.   
Because of their mechanical degradation properties (i.e. fibrin breaks down with 
fibrin hydrogels are not good candidates for pressure based extrusion printing. A 
composite hydrogel consisting of fibrinogen and gelatin was then prepared, using 
gelatin as a support material during the printing process, which then will be leached 
into the media. We tested two concentrations (5w/v% and 10w/v %) of each 
to achieve proper printing resolution. Each group of bioink was extruded to form a 
rectangular lattice, with defined fiber diameter and pore size. Pictures of each printed 
samples were taken immediately after printing and 24h after crosslinking in thrombin 
and incubation at 37°C to allow the gelatin to leach out ( 
Figure 6a). All of the images were then analyzed to measure changes in pore size. 
The bioink containing 10w/v% fibrinogen and 5w/v% gelatin had the lowest degree 
of either swelling or shrinking ( 
Figure 6b) which is ideal, and therefore was used for the remainder of the 




Figure 6b can be explained by two phenomena. First, a high concentration of fibrinogen 
has been shown to result in fibrin gels with an increased number of fibrin fibers and 
decreased porosity, which therefore does not absorb as much water as gels with lower 
fibrinogen concentrations 179. Second, gelatin was used here as a thickener agent and 
therefore was not modified and crosslinked. The gelatin contained in the sample was 






Figure 6 Fibrin bioink characterization. (a) Micrographs of 3D printed fibrin bioink (fibrinogen 5%, gelatin 5%) 
immediately after printing (top) and after 24h, following crosslinking of the fibrinogen and leaching of the gelatin 
(bottom). Fiber swelling is visible in this example.  Scale bar is 100 µm. (b) Change in pore size for each bioink 
groups (n=9). A negative change correlates to a swelling of the extruded fibers, while a positive change corresponds 
to a shrinking of the extruded fibers. Fibrinogen 10%w/v/ gelatin 5%w/v was the chosen bioink composition for 
following experiments. (c) Live/Dead images of extruded L929. Live cells (left) are stained green, dead cells (right) 
are stained red. Cells were counted using Image J in order to quantify cell viability. (d) Cell viability after extrusion 
in the 3D printer, as a function of extrusion pressure and needle size/shape (n=6). (e) Extruded fiber diameter as 
a function of extrusion pressure, plotting speed, and cell density for a needle with an inner diameter of 250µm, 
which was used in the following experiments (n=9). The baseline line represents the targeted fiber diameter (i.e. 
needle inner diameter). All data points represent mean ± standard deviation. 
 





Prior to printing full-size constructs, parameters influencing cell viability were 
investigated in order to select the most appropriate conditions to construct a highly 
viable cell-laden scaffold. Fibers of bioink seeded with L929 cells were extruded at 
variable pressure (1.5 to 3.5 bar), needle type (conical or cylindrical), and needle 
diameter (250µm and 400µm) to study the effect of pressure and needle 
on cell viability directly after printing. Extruded fibers were stained with Live/Dead 
and imaged ( 
Figure 6c). Images were processed and dead or live cells counted to quantify cell 
viability. Across all groups and for any pressure, cell viability was greater than 70% ( 
Figure 6d). For all tested needles, higher extrusion pressure resulted in decreased cell 
viability. Cell viability was dependent on needle type, with higher cell viability for 
conical needles at low pressure (<2 bar). However, for higher pressures (>2.5 bar), cell 
viability observed for cylindrical needles was significantly (p<0.05) higher than with 
conical needles. To understand the discrepancy between two needle types, finite 
element simulations were performed. The simulation demonstrated that for low 
pressure, higher shear stresses were shown for conical needles, but were only observed 
proximal to the fluid outlet, limiting exposure to high shear stress to this region. On the 
other hand, shear stresses in cylindrical needles were lower but for an increased passage 
length.  However, at higher pressure (>2.5 bar), as flow velocity increased, the passage 
time of cells in this high shear region is reduced and the limited exposure to shear stress 




The accuracy of a 3D printed sample depends on the accuracy of the extruded 
fibers. Fibers should be round and their diameter should theoretically match the inner 
diameter of the extrusion needle. The effects of extrusion pressure, plotting speed, 
cell density using different needle size, on extruded fibers diameter, and therefore 
printing accuracy, are shown in  
Figure 6e. Increased pressure and decreased speed resulted in larger fibers 
diameter, which was expected. The incorporation of cells altered the rheological 
properties (  
Figure 10), which was correlated with fiber diameters. While using a 400µm 
needle, results showed decreased fiber diameter with increased cell density, with 
smaller fibers (i.e. more viscous bioink) observed with the highest cell density. 
However, while using a 250µm needle, results showed no correlation between fibers 
diameter and cell density. This indicated that the viscosity of the low cell density bioink 
changed in function of the applied shear stress between needle sizes.  
 
PCL Carrier Scaffold Characterization 
The second objective was to improve the mechanical strength of the construct by co-
printing the fibrin bioink along a supporting PCL carrier scaffold. Tissue engineering 
scaffolds must retain sufficient mechanical properties to fulfill the requirements of 
structural integrity once implanted in vivo. Accordingly, we considered whether our 
osteon-like constructs had mechanical properties similar to that of bone. Dynamic 




0.7±0.3MPa under compression.  However, cortical bone compressive strength is in the 
range of 100-150MPa 184. In order to improve the mechanical strength of the construct, 
we designed and 3D printed PCL carrier scaffolds that would be co-printed along the 
fibrin bioink and would encase several fibrin hydrogels (Figure 7a).  Several PCL 
carrier scaffolds were 3D printed, with defined pore size, fiber diameter, center post 
and variable porosity (Figure 7b). Sufficiently high porosity and suitable pore size are 
required for spreading of cells and nutrients throughout the structure. An optimal pore 
size for bone tissue engineering scaffolds is not well defined, however pore sizes 
between 100 and 400μm are considered optimal for osteoconduction, and pore sizes 
greater than 300μm have been shown to enhance bone formation via vascularization 
185,186.  In order to evaluate printing accuracy, SEM images (Figure 7b) of the 3D printed 
constructs were analyzed in order to quantify the resulting pore size and fiber diameter. 
Across, all printed constructs, results showed that printed fibers were on average 
9.6±0.4% bigger than the designed ones, resulting in pores on average 18.2±1.7% 
smaller, due to spreading and thermal expansion of the PCL matrix during 3D printing. 
These results were taken into account when designing PCL 3D printed scaffolds for 
later experiments.   
Computational modeling of flow was performed and showed a homogeneous 
and sufficient fluid distribution throughout the scaffold, with minimum shear stress 
(Figure 7c). Finally, compressive mechanical testing was performed on 3D printed 
PCL scaffolds. Figure 7d shows a typical stress/strain curve from compression testing, 
with an initial increase in stress at low strain followed by a plateau region, with 




layer under compression. The compressive moduli of the porous scaffolds were 
quantified from the initial slope of the stress-strain curve in Figure 7d. All the PCL 
scaffolds showed improved mechanical properties with an average compressive 
modulus of 130.93±22.74MPa, which falls in the lower range of cortical bone 184.   
Figure 7 PCL Carrier Scaffold Characterization. (a) Schematic of 3D printed osteon-like scaffolds (green) and PCL 
carrier scaffold (gray).  (b) Micrograph of a 3D printed PCL/Fibrin scaffold. Yellow food coloring was added to the 
fibrin bioink for photography purpose. (c) Micrograph and SEM images of 3D printed PCL scaffolds, with variable 
central post diameter (1), fiber diameter (2), and pore size (3). (d) Computational modeling of flow and shear 
stress within 3DP scaffolds while under perfusion. (e) the strain-stress curve for four representative examples of 





In Vitro and In Vivo Evaluation of Osteon-like Scaffolds 
The third objective of this work was to test the osteogenic and angiogenic potential of 
osteon-like scaffolds, and demonstrated that a bio-inspired approach could enhance 
neovascularization of the graft. Constructs were 3D printed using the Bioplotter. As 
shown in Figure 8a and Figure 8b, the osteon-like unit had a concentric triple-ring 
structure with an outer diameter of 2.5 mm. A set of two bioink was used: one 
encapsulating hMSCs for the outer rings and one encapsulating HUVECs to recreate 
the Haversian canal in the center. After 14 days of in vitro culture, cells were retrieved 
and DNA and RNA were collected. The DNA quantification assay showed a 
significantly higher (p<0.05) DNA concentration in the printed samples compared to 
the casted samples (Figure 8c). In addition, a significant increase (p<0.05) in DNA 
concentration over the 14 days was found for the printed samples, while the casted 
samples showed no significant changes (p=0.084). Scaffolds were stained using 
Live/Dead to assay cell viability after 7 and 14 days of culture (Figure 8e). Cell viability 
was not significantly different (p=0.071) between control and experimental groups. 
After 14 days, cell viability was 94.8±2.8% for the printed samples. Rt-PCR showed 
an increase in gene expression of BMP2, ALP, VEGFA, and PECAM1 in both groups 
after 14 days (Figure 8d). However, while rt-PCR showed no significant difference in 
gene expression of osteogenic markers (p=0.098), a significant fold change (p<0.05) in 








Figure 8: Osteon-like scaffolds in-vitro experiment. (a) Schematic of 3D printed osteon-like scaffolds and casted 
controls. 3DP scaffolds are composed of four concentric fibrin fibers of 250µm in diameter, containing hMSCs for 
the three outermost rings, and HUVECs for the innermost ring. Casted samples containing a mixture of MSCs and 
HUVECs (2.10
6
 cells/ml) were used as controls. (b) Bioplotter picture of 3D printed constructs. The inner channel is 
350µm in diameter and the complete scaffold is 2.5 mm in diameter. (c) DNA quantification assay showed 
significant increase in DNA concentration (p<0.05) over 14 days of in vitro culture in the printed samples compared 
to the casted samples (n=9). In addition, a significant higher DNA concentration (p<0.05) was shown in the printed 
samples, while the casted samples showed no significant changes. (d) mRNA expression fold change between day 
0 and day 14 of in vitro culture (n=9). Rt-PCR showed no significant difference in gene expression of osteogenic 
markers (p=0.098), but a significant fold change in mRNA of angiogenic markers (p<0.05). (e) Live/Dead images of 
3D printed scaffolds at day 14 (n=3). Live cells are stained green, and dead cells are stained red. Cells were counted 





In vivo experiments were performed in order to demonstrate the ability of the 
construct to successfully integrate with the host tissue and assess the angiogenic 
potential of the scaffolds. Osteon-like samples, as well as MSCs/ECs,  casted controls, 
were implanted subcutaneously in rats (Figure 9a), with enough distance between them 
to be retrieved easily: the MSCs only control was implanted cranially, the MSCs/ECs 
control caudally and the 3D printed samples in the middle. After 14 days, the samples 
were retrieved. From simple visual inspection, experimental samples appeared to have 
a darker red color indicative of potential vascularization (Figure 9b). Further 
histological analyses were performed using Masson’s trichrome and Von Kossa (for 
mineralization) stains. No signs of inflammation (large fibrous capsule, giant cells) 
were observed in all groups. Masson’s trichrome stain showed a clear qualitative 
difference between samples (Figure 9c).  In the control sample, the fibrin hydrogel was 
still visible and the delimitation from surrounding tissue is clear. Cell invasion within 
the hydrogel had not reached the PCL carrier scaffolds, and few blood vessels were 
visible. The fibrin hydrogel from the 3D printed sample exhibited stronger blue 
staining, suggesting that more collagen had been deposited. The same observation was 
made with the Von Kossa stained samples (Figure 11): all groups showed increased 
mineralization between day 7 and day 14, but the 3D printed samples exhibited the 






Figure 9 Osteon-like scaffolds in-vivo experiments. (a) Schematic of a 3DP scaffolds. Osteon-like fibrin hydrogels 
are co-printed with PCL for support. Each 3DP sample comprises four osteon-like fibrin hydrogels, with a diameter 
of 6.4mm. Control samples consisted of fibrin bioink casted within the barrel of a 3 mm diameter syringe. Once 
gelled, control samples were casted out of the syringe using the plunger and assembled onto a 3D printed PCL 
scaffold. (b) Images of samples after 14 days implantation in vivo. TOP refers to the side of the implant with 
osteons, while BOTTOM refers to the side with the PCL support. (1) rMSCs only control scaffold, (2) rMSCs/RAECs 
control casted scaffold, and (3) rMSCs/RAECs 3DP osteon-like scaffold. (c) Micrographs of embedded, sectioned 
and stained samples using Masson Trichrome. Line (1) images of rMSCs/RAECs controls at day 14 after 
implantation. Line (2) images of 3DP rMSCs/RAECs at day 14 after implantation. Collagen is stained blue, cell nuclei 
are stained dark purple and fibrin is stained pink. Black arrows indicate blood vessels. (d) Quantitative analysis of 
Masson’s Trichrome images showing the percent area of the pictures covered by either collagen or cells, and the 
average number of blood vessels per picture (n=12). All data points represent mean ± standard deviation. Groups 




Quantitative assessment was performed using Image J. The percentage area of 
each picture covered by collagen or cells was measured and averaged. The number of 
blood vessels per area was also counted and averaged. No statistical difference in 
collagen deposition was observed between the three groups after 7 days. However, after 
14 days of in vivo culture, both groups containing ECs had a statistically higher 
collagen deposition than the MSCs only control. After 14 days of in vivo culture, no 
significant difference (p=0.087) in cell density between groups was observed. 
However, cell infiltration was more pronounced in the 3DP osteon-like groups, as 
shown by a statistically higher surface area (p<0.05) covered by cells after 7 days of 
culture. Finally, after 14 days of culture, blood vessels were observed throughout the 
scaffolds, and a significant increase (p<0.05) in the number of blood vessels per area 
in 3DP osteon-like samples was observed. 
In both the mixed and osteon-like scaffolds, the co-culture of ECs and MSCs 
improved the deposition of collagen, one marker of osteogenesis, and 
neovascularization. Numerous studies on ECs/MSCs coculture have been 
demonstrated to achieve enhanced cellular signaling. Both cell populations are known 
to secrete specific growth factors that are beneficial for mutual growth and 
differentiation for each other. MSCs promotes neovascularization by secreting pro-
angiogenic growth factor such as Ang-1, FGF-2 and, VEGF likely through paracrine 
communication between EPCs and MSCs, which simulates EPCs proliferation and 
differentiation187–189. In return, EPCs secrete osteogenic growth factors such as insulin 
growth factor 1, and BMP-2, promoting MSCs differentiation 34,190,191. In addition, 




neovascularization within the construct than the two other control groups. MSCs 
paracrine factors production and release has been shown to vary with the substrate 
microarchitecture, stiffness or composition 35,192,193; although it remains to be proved, 
we contend that the specific respective patterning of cells, in this case in the shape of 
osteons, could also affect paracrine signaling or other cell-cell communications, and 
result in an improved neovascularization. Thus, further experiments are warranted to 
explain the observed phenomena, and relevant research is progressing in our laboratory. 
In addition, this osteon-like scaffold could be further optimized to improve its bio-
inspired characteristic, for example scaling by incorporating a non-organic phase 
(hydroxyapatite) to the bioink. 
 
Conclusions  
In the present study, we demonstrated the successful fabrication of a novel 3DP 
fibrin-PCL composite scaffold, with mechanical strength comparable to bone, a stable 
swelling behavior and cell bioactivity for the construction of bio-inspired structures.  
Using 3D printing technologies, bioinks were patterned into varied geometries and with 
controlled dimensions, in order to recreate an optimal microenvironment mimicking 
the native natural cell pattern found in bones, to form a simplified model of osteons. 
Most importantly, the utilization of these scaffolds in constructing bio-inspired osteons 
for bone regeneration demonstrated a promising capacity to improve 
neovascularization of the construct. These results indicate that proper cell orientation 




between cell populations, introduced via 3D printing, is explored in the next chapter. 
This bio-inspired osteon-like construct holds potential to be developed as scaffolds in 
vascularized bone tissue engineering. In addition, advancements in the field of 3D 
printing, and a higher level of precision will allow the printing of ever more bio-






Figure 10:  Supplemental Data: Fibrin bioink printing accuracy. (a) Extruded fiber diameter as a function of 
extrusion pressure, plotting speed, and cell density for variable needle inner diameter (n=9). The baseline line 
represents the targeted fiber diameter (i.e. needle inner diameter). (b) Rheological evaluation of fibrin bioink 
seeded with variable density of L929s. The printing shear rate was calculated for every printing condition, the 
printing shear rate range is represented in black. (c) Bioplotter image of extruded fibers used to measure extruded 





Figure 11: Supplemental Data: Von Kossa staining.  Micrographs of embedded, sectioned and stained samples 
(rMSCs only, rMSCs/RAECs control or rMSCs/RAECs 3DP) using Von Kossa, 7 or 14 days implantation in vivo.  
Calcium deposits are stained brown to dark depending on UV exposure. 0.1% Nuclear Fast Red Solution was used 
as a counterstain, staining nuclei pink. Von Kossa staining showed increased mineralization between day 7 and day 





Chapter 5:  Cell-to-Cell distance of HUVECS and MSCs in 3D 




It is well established that human umbilical vein endothelial cells (HUVECs) 
and human mesenchymal stem cells (hMSCs) secrete specific growth factors that are 
mutually beneficial. For example,  endothelial cells are known to secrete growth factors 
such as insulin growth factor-1 33, endothelin-1, and bone morphogenic protein-2, 
promoting osteogenic growth and differentiation of the MSCs 34.  
Recently, studies suggested that cell-cell communication and paracrine secretion can 
be affected by the substrate microarchitecture 35, mechanical environment 36 or the 
matrix stiffness 37. However, little is known about the effect of cell patterning and the 
distance between cell populations on their crosstalk. The precisely regulated 
architecture of different tissue types, such as osteons in bones, indicates that 
characteristic features related to the number, types, and spacing of cells might be 
critical to tissue function. We previously demonstrated that an osteon-like scaffold, 
with specific patterning of HUVECs and MSCs, improved neovascularization of the 
implant in vivo 194.  
Until recently, recapitulating complex hierarchical structures in vitro has 
proved difficult due to limited manufacturing techniques, particularly while using 




builds 3D constructs by extruding fibers of cell-laden materials in a layer-by-layer 
fashion, offers a unique opportunity in tissue engineering, by enabling precise 
positioning of cells and biomaterials, tunable mechanical properties, fine control of the 
external and internal architecture 182. Controlling those specific parameters can 
modulate cellular effects. For example, pore sizes of at least 300 µm have been shown 
to enhance bone formation and vascularization 185. Could 3D printing also be used to 
improve angiogenesis by modulating the crosstalk between EC and MSCs, through the 
precise control of the distance between fibers? 
In the present study, the overall objective was to investigate how the distance 
between 3D printed fibers (i.e. separation and distance between ECs and MSCs 
populations) affects angiogenesis by modulating cell-cell communication in different 
3D printed co-cultures (Figure 12: Methods. (a) Chart showing the different 
experimental groups: Endothelial Cells (ECs), Mesenchymal Stem Cells (MSCs), 
Mixed, and Separated with a distance of 0µm (D0), 200µm (D1), 400µm (D2) between 
fibers. ECs/MSCs groups are made of adjacent fibers containing only ECs/MSCs, 
respectively. The bioink for the mixed group contains both ECs/MSCs, and the fibers 
are also printed adjacent to each other. For the D0, D1, D2 groups, ECs and MSCs are 
encapsulated in different bioinks, and the fibers are printed alternatively and with a 
distance of 0, 200, 400µm between them. (b) Micrographs of 3D printed samples (D0, 
D1, D2). All samples are 8mm diameter and 1mm thick discs. All samples were stained 
directly after printing, using calcein, showing live cells in green. Using ImageJ, the 




d(D2)=381.7±25.97µm. (c) After printing, 3D printed samples were incubated for 48h 
in serum free media. After 48h, the media was collected and the ECs from the samples 
were magnetically sorted. ). ECs and MSCs can communicate through three 
mechanisms: (i) the direct interaction between membrane molecules of the two adjacent 
cells (tight junctions, adherent junctions), the secretion of (ii) diffusible factors that 
diffuse freely in the extracellular environment and interact with the target cells through 
specific receptors, and (iii) the release of extracellular vesicles (EVs). To this end, we 
separately analyzed ECs grown in different co-culture conditions and, the paracrine 
secretions and the released EVs in the conditioned media. Finally, we used functional 
assays to study the cells and conditioned media angiogenic potential. In vitro 
angiogenesis assays provide a valuable tool for assessing the effect of angiogenic 
products as they enable the analysis of isolated processes that contribute to 
angiogenesis, such as ECs migration, proliferation, sprouting, branching, and lumen 
formation 56. 
 
Materials and Methods 
Cell culture 
hMSCs (RoosterBio, Frederick, MD) were cultured in RoosterBasal Media 
supplemented with RoosterBooster, as per the manufacturer's specifications. Cells were 
expanded on tissue culture polystyrene flasks for 5 days and grown to 90% confluency 





HUVECs (Lonza) were cultured in EBM‐2 Basal Medium (Lonza) supplemented by 
EGM‐2 SingleQuot Kit. Cells were expanded on tissue culture polystyrene flasks with 
media changes every 3 days and grown to 80% confluency before being passaged using 
trypsin/EDTA. Cells at passage P4 were used for the experiments. 
3D Printed Cocultures Preparation 
All samples, for the six experimental groups (Figure 12: Methods. (a) Chart showing 
the different experimental groups: Endothelial Cells (ECs), Mesenchymal Stem Cells 
(MSCs), Mixed, and Separated with a distance of 0µm (D0), 200µm (D1), 400µm (D2) 
between fibers. ECs/MSCs groups are made of adjacent fibers containing only 
ECs/MSCs, respectively. The bioink for the mixed group contains both ECs/MSCs, and 
the fibers are also printed adjacent to each other. For the D0, D1, D2 groups, ECs and 
MSCs are encapsulated in different bioinks, and the fibers are printed alternatively and 
with a distance of 0, 200, 400µm between them. (b) Micrographs of 3D printed 
samples (D0, D1, D2). All samples are 8mm diameter and 1mm thick discs. All samples 
were stained directly after printing, using calcein, showing live cells in green. Using 
ImageJ, the distance between fibers was calculated: d(D1)= 195.14±25.4µm and 
d(D2)=381.7±25.97µm. (c) After printing, 3D printed samples were incubated for 48h 
in serum free media. After 48h, the media was collected and the ECs from the samples 
were magnetically sorted. a), were 3D printed using a commercial 3D printing system 
(3D Bioplotter, EnvisionTEC, Gladbeck, Germany). All printing supplies (30cc barrel 
and 200 µm precision tips) were purchased from Nordson EFD (RI, USA). All 3D 




comprised of concentric fibers (200µm) separated from each other by a distance of 
either 0, 200 µm or 400 µm (Figure 12: Methods. (a) Chart showing the different 
experimental groups: Endothelial Cells (ECs), Mesenchymal Stem Cells (MSCs), 
Mixed, and Separated with a distance of 0µm (D0), 200µm (D1), 400µm (D2) between 
fibers. ECs/MSCs groups are made of adjacent fibers containing only ECs/MSCs, 
respectively. The bioink for the mixed group contains both ECs/MSCs, and the fibers 
are also printed adjacent to each other. For the D0, D1, D2 groups, ECs and MSCs are 
encapsulated in different bioinks, and the fibers are printed alternatively and with a 
distance of 0, 200, 400µm between them. (b) Micrographs of 3D printed samples (D0, 
D1, D2). All samples are 8mm diameter and 1mm thick discs. All samples were stained 
directly after printing, using calcein, showing live cells in green. Using ImageJ, the 
distance between fibers was calculated: d(D1)= 195.14±25.4µm and 
d(D2)=381.7±25.97µm. (c) After printing, 3D printed samples were incubated for 48h 
in serum free media. After 48h, the media was collected and the ECs from the samples 
were magnetically sorted. b).  
Type A porcine gelatin (300g Bloom), fibrinogen and thrombin from bovine plasma 
were purchased from Sigma. The bioink was prepared by mixing 10w/v% fibrinogen 
and 5w/v% gelatin and heating to 60°C for 15 min. Cells were then passaged, 
suspended in media and centrifuged to form a pellet. After aspiration of the supernatant, 
the pellet was then suspended in the fibrin bioink by manual pipetting, until the solution 
was homogenous and all clumps were broken down. Three fibrin bioink formulations 




density of 2x106 cells/mL and (3) a mixed of HUVECs and MSCs (ratio 1:1) at a 
density of 2x106 cells/mL. The fibrin bio inks were then loaded into low-temperature 
printer heads and allowed to equilibrate for 30 min at a 22°C. Printed constructs were 
crosslinked in 100 U thrombin for 30 min, rinsed in Phosphate Buffer Saline (PBS), 
and incubated in serum-free basal media for 48h.  
MACS-mediated selection of HUVECS 
Cell samples from each group were isolated from fibrin hydrogels after 48h coculture 
by dissolution in 1 mg/mL collagenase (Sigma) for 30 min at 37°C and a cell pellet was 
formed by centrifugation and washed with PBS three times. HUVECs were positively 
selected for CD31 by magnetic cell sorting (MACS) using MS separation columns 
(Miltenyi Biotech, Bergisch Gladbach, Germany). Following the manufacturer's 
instructions, a positive selection for ECs using the CD31 MicroBead Kit (Miltenyi) was 
performed. PBS was used for the final washing step and elution from the column. The 
CD31+ population (HUVECs) was used in subsequent assays of endothelial function.  
Flow Cytometry (FACS) 
Cells sorting was confirmed by flow cytometry prior to use. Harvested and sorted cells 
suspensions were adjusted to a concentration of 1x106 cells/mL in cold PBS, 10% FCS, 
and 1% sodium azide. 10 μg/mL of FITC conjugated anti-CD31 antibody (Abcam, 
Cambridge, UK) was added to the suspension and incubated for 30 min in the dark, at 
room temperature. Cells were then washed 3 times by centrifugation at 400 x g for 5 
min before being resuspended. Flow cytometry was performed on a BD FACSCelesta. 




Total RNA from HUVECs obtained after MACS-mediated separation was isolated 
using the RNeasy Plus Mini Kit (Qiagen), following the supplier’s protocol (n=9). 
Reverse transcription was performed using TaqMan Reverse Transcription reagents 
(Applied Biosystems) following the supplier’s protocol. qRT-PCR was performed 
using TaqMan PCR Master mix and TaqMan Gene Expression Assays for vascular 
endothelial growth factor-A (VEGF), platelet and endothelial cell adhesion molecule-
1 (PECAM), von Willebrand factor (VWF), vascular endothelium cadherin 5 (CDH5), 
and integrin subunit alpha 5 (ITGA5). Quantification of target gene expression was 
calculated relative to the reference glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) gene. The mean minimal cycle threshold values (Ct) were calculated from 
triplet reactions.  
Enzyme-Linked Immunosorbent Assay (ELISA) 
For all experimental groups reported in Figure 1a, conditioned media (CdM) was 
collected after 72h of incubation. CdM media was concentrated using 100 kDa MWCO 
cut-off filters (Spin-X UF Concentrator, Corning, NY). ELISA kits (Abcam, 
Cambridge, UK) were used, as per manufacturer instructions, to quantify VEGF, 
fibroblast growth factor (FGF), angiopoietin 1 (Ang-1) and insulin-like growth factor 
1 (IGF1) concentration in the concentrated CdM. 
 
EVs Collection and quantification 
EV-containing conditioned media (CdM) was collected after the samples were 




as reported previously 195. After initial centrifugation steps to remove cellular debris 
and larger vesicles, EVs were pelleted in a final 118,000 x g ultracentrifugation step. 
EVs were then resuspended in PBS and washed with Nanosep 300kDa MWCO spin 
filters (Pall, NY). EV yield was measured by determining the total protein 
concentration and particle concentration, via bicinchoninic acid assay (BSA) using the 
manufacturer’s protocol and nanoparticle tracking analysis, respectively. Nanoparticle 
tracking analysis was performed using a Nanosight LM10, software version 2.3.     
Functional Angiogenic Assays 
The following assays were performed with at least one of the following conditions: (1) 
using sorted CD31+ HUVECs and EBM‐2 Basal Medium (Lonza) supplemented by 
EGM‐2 SingleQuot Kit, (2) P4 HUVECs (Lonza) and serum-free basal media 
supplemented with 10% CdM, or (3) P4 HUVECs (Lonza) and serum-free basal media 
supplemented with 50 µg/ml EVs. P4 HUVECs with full EBM-2 media were used as 
a positive control, and P4 HUVECs with unsupplemented basal media were used as a 
negative control. 
Proliferation Assay. HUVECs were seeded in 24 well plates at a density of 15,000 cells 
per well and incubated for 36h.  Images of the wells were taken using an inverted 
microscope (Nikon Eclipse Ti2) and analyzed using ImageJ to measure the confluency 
(i.e cell surface area) (Supplemental Figure 12: Methods. (a) Chart showing the 
different experimental groups: Endothelial Cells (ECs), Mesenchymal Stem Cells 
(MSCs), Mixed, and Separated with a distance of 0µm (D0), 200µm (D1), 400µm (D2) 




ECs/MSCs, respectively. The bioink for the mixed group contains both ECs/MSCs, and 
the fibers are also printed adjacent to each other. For the D0, D1, D2 groups, ECs and 
MSCs are encapsulated in different bioinks, and the fibers are printed alternatively and 
with a distance of 0, 200, 400µm between them. (b) Micrographs of 3D printed 
samples (D0, D1, D2). All samples are 8mm diameter and 1mm thick discs. All samples 
were stained directly after printing, using calcein, showing live cells in green. Using 
ImageJ, the distance between fibers was calculated: d(D1)= 195.14±25.4µm and 
d(D2)=381.7±25.97µm. (c) After printing, 3D printed samples were incubated for 48h 
in serum free media. After 48h, the media was collected and the ECs from the samples 
were magnetically sorted. a).  
Migration Assay. The scratch wound assay is a simple, quick and inexpensive method 
to quantify ECs migration. It is based on the ability of EC to fill an area that has been 
mechanically ‘wounded’ using a pipette tip on a confluent monolayer of ECs 56. 
HUVECs were seeded in 48 well plates at a density of 30,000 cells per well, and 
incubated for 24h or until a uniform monolayer was formed.  The monolayer was then 
“scratched” using a pipette tip to create a linear gap through the middle of each well. 
Medium (EBM-2, CdM or EVs) was added. Images of the wells were taken using an 
inverted microscope (Nikon Eclipse Ti2) after 0h and 12h of incubation. Pictures were 
analyzed using ImageJ to determine the overall gap closure, as previously described 57.  
Tube Formation Assay. In vitro assays that simulate the formation of capillary-like 
structures can be used to investigate late stages of the angiogenic process 196. 96 well 




30min at 37°C. HUVECs were seeded in coated 96 well plates at a density of 15,000 
cells per well and incubated for 18h. Images of the wells were taken using an inverted 
microscope (Nikon Eclipse Ti2) and analyzed using ImageJ and Angiogenesis 
Analyzer plugin 197 to measure the confluency (i.e cell surface area) (Supplemental 
Figure 12: Methods. (a) Chart showing the different experimental groups: 
Endothelial Cells (ECs), Mesenchymal Stem Cells (MSCs), Mixed, and Separated with 
a distance of 0µm (D0), 200µm (D1), 400µm (D2) between fibers. ECs/MSCs groups 
are made of adjacent fibers containing only ECs/MSCs, respectively. The bioink for the 
mixed group contains both ECs/MSCs, and the fibers are also printed adjacent to each 
other. For the D0, D1, D2 groups, ECs and MSCs are encapsulated in different bioinks, 
and the fibers are printed alternatively and with a distance of 0, 200, 400µm between 
them. (b) Micrographs of 3D printed samples (D0, D1, D2). All samples are 8mm 
diameter and 1mm thick discs. All samples were stained directly after printing, using 
calcein, showing live cells in green. Using ImageJ, the distance between fibers was 
calculated: d(D1)= 195.14±25.4µm and d(D2)=381.7±25.97µm. (c) After printing, 3D 
printed samples were incubated for 48h in serum free media. After 48h, the media 
was collected and the ECs from the samples were magnetically sorted. a).  
Permeability Assay.  24 well plates and 0.4-mm pore size inserts were obtained from 
BD Biosciences. HUVECs were seeded at 60,000 cells per insert well in a total volume 
of 1.5mL of EBM-2 media and incubated overnight to allow the cell to form a uniform 
monolayer.  HUVECs monolayer permeability was tested by adding 150 µL of 10 




upper chamber of each well. Media samples were taken in the bottom chamber of the 
well after 5, 60, 120, 240min. Measurements were determined with a Spark Multimode 
Microplate Reader (Tecan) using excitation and emission wavelengths of 485 and 
530nm, respectively.  
Statistical Analysis 
Data were analyzed using single factor analysis of variance (ANOVA) followed by 
Tukey’s Multiple Comparison Test assuming normal data distribution with a 







Figure 12: Methods. (a) Chart showing the different experimental groups: Endothelial Cells (ECs), Mesenchymal 
Stem Cells (MSCs), Mixed, and Separated with a distance of 0µm (D0), 200µm (D1), 400µm (D2) between fibers. 
ECs/MSCs groups are made of adjacent fibers containing only ECs/MSCs, respectively. The bioink for the mixed 
group contains both ECs/MSCs, and the fibers are also printed adjacent to each other. For the D0, D1, D2 groups, 
ECs and MSCs are encapsulated in different bioinks, and the fibers are printed alternatively and with a distance of 
0, 200, 400µm between them. (b) Micrographs of 3D printed samples (D0, D1, D2). All samples are 8mm diameter 
and 1mm thick discs. All samples were stained directly after printing, using calcein, showing live cells in green. Using 
ImageJ, the distance between fibers was calculated: d(D1)= 195.14±25.4µm and d(D2)=381.7±25.97µm. (c) After 
printing, 3D printed samples were incubated for 48h in serum free media. After 48h, the media was collected and 





Results and Discussion 
HUVECs grown ≤200µm from ECs condition show characteristics of later 
stage angiogenesis. 
The first objective of this work was to study the angiogenic potential of ECs 
grown in different co-culture conditions, i.e. separated from MSCs by various distances 
(0, 200 µm, 400 µm). After 48h of incubation, cells were isolated from the 3D printed 
samples (Fig. I). HUVECs uniformly express high levels of CD31. This marker was 
used to positively select HUVECs from MSC-HUVEC mixed cultures using MACS. 
As determined by fluorescence-activated cell sorting analysis, MACS separation of 
MSC-HUVEC cocultures yields a very pure population of CD31 HUVECs (Fig. IIb) 
that was subsequently tested using qPCR and angiogenic assays.  
Figure 13: ECs grown in close (≤200µm) coculture condition show characteristics of 
a later stage angiogenesis. (a) Schematic of the experiment. Cells were collected from 
the 3D printed samples after 48h of incubation. HUVECs were sorted using CD31 
MACS, and used in subsequent experiments. (b) FACS analysis, pre and post-
separation. The bottom row confirms the positive selection of HUVECs (c) Rt-PCR 
showed an increase in gene expression of VEGF and FGF-2 for cells isolated from D2 
samples and an increase in the fold change in mRNA of Ang-1 for cells isolated from 
D0/D1 samples. (d) Cell confluency after 24h of incubation. D2 cells exhibit a 
significantly higher proliferation rate than the other groups. (e) Permeabilization 
Assay. Diffusion of Dextran-FITC was observed through a confluent monolayer of 




showed an increase in gene expression of ITGA5 for the same cells. c shows the 
expression of three angiogenic markers (VEGFA, FGF2, and ANG1) in all 
experimental groups. ECs grown by themselves were used as a control. All three groups 
with separated cell populations (D0, D1, and D2) showed an increase in gene 
expression of VEGF-A and FGF-2 when compared to the mixed group; with D2 
samples showing the most up-regulation of both genes. However, only D0 and D1 
samples showed an important increase in fold change for Ang-1. Sorted HUVECs were 
also used to study proliferation (Fig. IId). Cells were seeded in well plates at the same 
density, and confluency was measured after 24h of incubation. P4 HUVECs in growth 
media were used as a positive control, and P4 HUVECs with unsupplemented basal 
media were used as a negative control. Both mixed and D2 samples showed a 
significant increase in confluency (p<0.05) when compared to the positive control. D2 
sample’s cells showed the most mitotic activity, with a significantly higher 
proliferation rate.  
rt-PCR was also performed to study the expression of genes associated with 
cellular junctions: ITGA5 (integrin) and CDH5 (VE-cadherin). VE-cadherin was the 
most up-regulated in D0 and D1 groups while ITGA3 was up-regulated with a higher 
expression in D2 groups (Fig. IIe). Finally, isolated and sorted HUVECs were grown 
to confluence on a transwell membrane and transport of Dextran-FITC across the 
monolayer was measured for 4h. Figure 13: ECs grown in close (≤200µm) coculture 
condition show characteristics of a later stage angiogenesis. (a) Schematic of the 
experiment. Cells were collected from the 3D printed samples after 48h of incubation. 




analysis, pre and post-separation. The bottom row confirms the positive selection of 
HUVECs (c) Rt-PCR showed an increase in gene expression of VEGF and FGF-2 for cells 
isolated from D2 samples and an increase in the fold change in mRNA of Ang-1 for cells 
isolated from D0/D1 samples. (d) Cell confluency after 24h of incubation. D2 cells 
exhibit a significantly higher proliferation rate than the other groups. (e) 
Permeabilization Assay. Diffusion of Dextran-FITC was observed through a confluent 
monolayer of HUVECs. Cells isolated from D2 samples showed the highest 
permeability. Rt PCR showed an increase in gene expression of ITGA5 for the same 
cells. e shows that monolayers, from cells isolated from D2 samples, were significantly 
the most permeable than monolayers from D0 and D1 cells.  
Angiogenesis is a complex, multistep process that includes endothelial cell 
proliferation, guided migration, the formation of tubular structures, stabilization of 
newly formed vessels by deposition of the basement membrane, and finally the 
recruitment of perivascular supporting cells 198,199. This process is highly regulated and 
involves numerous factors 40. In response to angiogenic stimuli, such as VEGF or FGF-
2, ECs turn from a quiescent to an active phenotype characterized by a high mitotic 
index and increased capacity for migration and matrix proteolysis 200. Proteolytic 
enzymes produced and secreted by endothelial cells, such as Matrix metalloproteinase 
(MMP) family members, lead to cell-directed matrix degradation and remodeling, and 
they further growth factor delivery of matrix-bound growth factors. The early stages of 
angiogenesis, proliferation, and migration, in addition to VEGF and FGF-2, are also 




its receptor Tie-2, promoting vascular destabilization and a change in ECs adhesive 
properties 201.   
VE-cadherin is an adhesion molecule that mediates cell-to-cell contact between 
endothelial cells and not only plays a relevant role in the maintenance of vascular 
integrity but also limits endothelial cell proliferation 202. When ECs migrate during 
vessel sprouting, VE-cadherin junctions are temporarily dissolved. Once tubular 
structures are formed ECs suppress their motile phenotype and new adhesive 
interactions are established 203. Integrins, in particular, the α5 subunits, are cell-surface 
receptors of specific ECM molecules that assist ECs to build new vessels and are 
strongly linked to the initial steps of angiogenesis. Integrins expressed by ECs is 
stimulated by angiogenic growth factors, such as FGF-2 204, and facilitate EC adhesion 
to the extracellular matrix and their migration 205. Ang-1, a later marker of 
angiogenesis, exerts a vessel-sealing effect, by stabilizing the endothelium and 
reducing integrins expression 206.  
The results presented in Figure 13: ECs grown in close (≤200µm) coculture 
condition show characteristics of a later stage angiogenesis. (a) Schematic of the 
experiment. Cells were collected from the 3D printed samples after 48h of incubation. 
HUVECs were sorted using CD31 MACS, and used in subsequent experiments. (b) FACS 
analysis, pre and post-separation. The bottom row confirms the positive selection of 
HUVECs (c) Rt-PCR showed an increase in gene expression of VEGF and FGF-2 for cells 
isolated from D2 samples and an increase in the fold change in mRNA of Ang-1 for cells 




exhibit a significantly higher proliferation rate than the other groups. (e) 
Permeabilization Assay. Diffusion of Dextran-FITC was observed through a confluent 
monolayer of HUVECs. Cells isolated from D2 samples showed the highest 
permeability. Rt PCR showed an increase in gene expression of ITGA5 for the same 
cells.  suggest that HUVECs grown the farther apart from MSCs (D2) are at an earlier 
stage of angiogenesis (migration/proliferation) than D0/D1 cells. Indeed, results 
showed an increase in the up-regulation of VEGF, FGF-2, and ITGA3 (integrins) but a 
smaller fold change in the expression of VE-Cadherin and Ang-1. HUVECs isolated 
from D2 samples were also still highly proliferative when compare to D0/D1 cells. On 
the contrary, HUVECs incubated closer (≤200µm) to MSCs, started to show signs of 






Figure 13: ECs grown in close (≤200µm) coculture condition show characteristics of a later stage angiogenesis. 
(a) Schematic of the experiment. Cells were collected from the 3D printed samples after 48h of incubation. 
HUVECs were sorted using CD31 MACS, and used in subsequent experiments. (b) FACS analysis, pre and post-
separation. The bottom row confirms the positive selection of HUVECs (c) Rt-PCR showed an increase in gene 
expression of VEGF and FGF-2 for cells isolated from D2 samples and an increase in the fold change in mRNA of 
Ang-1 for cells isolated from D0/D1 samples. (d) Cell confluency after 24h of incubation. D2 cells exhibit a 
significantly higher proliferation rate than the other groups. (e) Permeabilization Assay. Diffusion of Dextran-FITC 
was observed through a confluent monolayer of HUVECs. Cells isolated from D2 samples showed the highest 




The crosstalk between hMSC and HUVECs is regulated by the separation and 
distance of cell populations. 
The second objective of this work was to investigate whether several soluble 
factors which may influence HUVECs behavior are differentially secreted by cells 
grown in different 3D printed coculture for 48h. The concentration of three common 
growth factors (VEGFA, FGF2, and Ang-1) was measured using ELISA (Figure 14: 
The crosstalk between hMSC and HUVECs is regulated by the separation and 
distance of cell populations. (a) Schematic of the experiments. After 48h of 
incubation, CdM was collected and concentrated. Different growth factors 
concentration was measured using ELISAs. Finally the CdM was used to supplement 
media in functional Angiogenic assays. (b) Concentration of VEGFA, FGF-2 and Ang-1 
in CdM from all experimental groups. For each growth factor, groups not sharing a 
letter are statistically different. Paracrine secretions were significantly increased in 
coculture groups where HUVECs were separated from MSCs (D0, D1). (c) CdM was 
used to supplement media in a proliferation assay. HUVECs confluency after 24h was 
measured. No statistical difference was observed between coculture groups. (d) CdM 
was used to supplement media for migration assay. Picture of the wound were taken 
12h after “scratching” a confluent monolayer of HUVECs, and the wound closure was 
calculated. Groups incubated with CdM from coculture in which HUVECs and MSCs 
were grown the farther apart (D2) show a significant increase in migratory activity. (e) 




with CdM from coculture in which HUVECs and MSCs were grown separated but close 
(<200 µm) (D0, D1) formed a significantly longer network.b).  
Results indicates a significant increase (p<0.05) in VEGFA and FGF2 secretions 
between MSCs cultured in isolation (731.03 pg/ml and 495.43 pg/ml respectively) and 
ECs cultured in isolation (306.26 pg/ml and 227.44 pg/ml respectively). In addition, 
VEGFA and FGF2 were secreted at a significant higher rate by HUVECs and MSCs in 
“mixed” coculture than HUVECs alone; both concentrations were even higher than the 
average of ECs alone and MSCs alone, confirming that co-culture improves paracrine 
secretion of ECs. Those findings are widely supported by literature: MSCs have been 
shown to be pro-angiogenic, and be able to activate ECs that will in return secrete more 
VEGFA and FGF2 207–209. The levels of VEGFA and FGF2 in D0/D1 CdM was also 
significantly higher than the ones from “mixed” cocultures. In addition, Ang-1 levels 
are significantly higher in D0/D1 groups (p<0.05). Those results match the qPCR 
results found in Figure 13: ECs grown in close (≤200µm) coculture condition show 
characteristics of a later stage angiogenesis. (a) Schematic of the experiment. Cells 
were collected from the 3D printed samples after 48h of incubation. HUVECs were 
sorted using CD31 MACS, and used in subsequent experiments. (b) FACS analysis, pre 
and post-separation. The bottom row confirms the positive selection of HUVECs (c) Rt-
PCR showed an increase in gene expression of VEGF and FGF-2 for cells isolated from 
D2 samples and an increase in the fold change in mRNA of Ang-1 for cells isolated from 
D0/D1 samples. (d) Cell confluency after 24h of incubation. D2 cells exhibit a 




Assay. Diffusion of Dextran-FITC was observed through a confluent monolayer of 
HUVECs. Cells isolated from D2 samples showed the highest permeability. Rt PCR 
showed an increase in gene expression of ITGA5 for the same cells. : D0/D1 coculture 
cells show both an up-regulation of Ang-1 gene and an increased secretion in Ang-1 
when compared to cells from D2 groups. However, D2 CdM contained significantly 
lower levels of both VEGFA and FGF2 (p<0.05), while it was previously shown in 
Figure 13: ECs grown in close (≤200µm) coculture condition show characteristics of 
a later stage angiogenesis. (a) Schematic of the experiment. Cells were collected from 
the 3D printed samples after 48h of incubation. HUVECs were sorted using CD31 
MACS, and used in subsequent experiments. (b) FACS analysis, pre and post-
separation. The bottom row confirms the positive selection of HUVECs (c) Rt-PCR 
showed an increase in gene expression of VEGF and FGF-2 for cells isolated from D2 
samples and an increase in the fold change in mRNA of Ang-1 for cells isolated from 
D0/D1 samples. (d) Cell confluency after 24h of incubation. D2 cells exhibit a 
significantly higher proliferation rate than the other groups. (e) Permeabilization 
Assay. Diffusion of Dextran-FITC was observed through a confluent monolayer of 
HUVECs. Cells isolated from D2 samples showed the highest permeability. Rt PCR 
showed an increase in gene expression of ITGA5 for the same cells.  that the gene for 
both those growth factors was the most up-regulated. This suggests that genetic 
material is not being transduced into proteins or that VEGFA and FGFs are not being 
secreted via paracrine signaling by the cells in the D2 group, but most likely using 




 A second set of experiments was conducted to investigate whether cell viability 
(Figure 14: The crosstalk between hMSC and HUVECs is regulated by the separation 
and distance of cell populations. (a) Schematic of the experiments. After 48h of 
incubation, CdM was collected and concentrated. Different growth factors 
concentration was measured using ELISAs. Finally the CdM was used to supplement 
media in functional Angiogenic assays. (b) Concentration of VEGFA, FGF-2 and Ang-1 
in CdM from all experimental groups. For each growth factor, groups not sharing a 
letter are statistically different. Paracrine secretions were significantly increased in 
coculture groups where HUVECs were separated from MSCs (D0, D1). (c) CdM was 
used to supplement media in a proliferation assay. HUVECs confluency after 24h was 
measured. No statistical difference was observed between coculture groups. (d) CdM 
was used to supplement media for migration assay. Picture of the wound were taken 
12h after “scratching” a confluent monolayer of HUVECs, and the wound closure was 
calculated. Groups incubated with CdM from coculture in which HUVECs and MSCs 
were grown the farther apart (D2) show a significant increase in migratory activity. (e) 
CdM was used to supplement media for a tube formation assay. HUVECs incubated 
with CdM from coculture in which HUVECs and MSCs were grown separated but close 
(<200 µm) (D0, D1) formed a significantly longer network.c) and migration (Figure 14: 
The crosstalk between hMSC and HUVECs is regulated by the separation and 
distance of cell populations. (a) Schematic of the experiments. After 48h of 
incubation, CdM was collected and concentrated. Different growth factors 




media in functional Angiogenic assays. (b) Concentration of VEGFA, FGF-2 and Ang-1 
in CdM from all experimental groups. For each growth factor, groups not sharing a 
letter are statistically different. Paracrine secretions were significantly increased in 
coculture groups where HUVECs were separated from MSCs (D0, D1). (c) CdM was 
used to supplement media in a proliferation assay. HUVECs confluency after 24h was 
measured. No statistical difference was observed between coculture groups. (d) CdM 
was used to supplement media for migration assay. Picture of the wound were taken 
12h after “scratching” a confluent monolayer of HUVECs, and the wound closure was 
calculated. Groups incubated with CdM from coculture in which HUVECs and MSCs 
were grown the farther apart (D2) show a significant increase in migratory activity. (e) 
CdM was used to supplement media for a tube formation assay. HUVECs incubated 
with CdM from coculture in which HUVECs and MSCs were grown separated but close 
(<200 µm) (D0, D1) formed a significantly longer network.d) of HUVECs were 
modulated by CdM from different co-culture conditions. The proliferation of HUVECs 
was significantly stimulated when cultured with CdM media regardless of the type of 
coculture, as compared to the negative control or CdM from ECs and MSCs cultured 
in isolation. However, no significant difference was observed between groups 
supplemented with CdM from “mixed”, D0, D1 and D2 cocultures. HUVEC migratory 
activity when cultured with CdM increased with distance between co-cultured 
HUVECs and hMSC. Quantification of the invaded area indicated that wound closure 




We then investigated whether tube-like structures are differentially generated in 
HUVECs cultures incubated in growth media supplemented with CdM (Figure 14: The 
crosstalk between hMSC and HUVECs is regulated by the separation and distance of 
cell populations. (a) Schematic of the experiments. After 48h of incubation, CdM was 
collected and concentrated. Different growth factors concentration was measured 
using ELISAs. Finally the CdM was used to supplement media in functional Angiogenic 
assays. (b) Concentration of VEGFA, FGF-2 and Ang-1 in CdM from all experimental 
groups. For each growth factor, groups not sharing a letter are statistically different. 
Paracrine secretions were significantly increased in coculture groups where HUVECs 
were separated from MSCs (D0, D1). (c) CdM was used to supplement media in a 
proliferation assay. HUVECs confluency after 24h was measured. No statistical 
difference was observed between coculture groups. (d) CdM was used to supplement 
media for migration assay. Picture of the wound were taken 12h after “scratching” a 
confluent monolayer of HUVECs, and the wound closure was calculated. Groups 
incubated with CdM from coculture in which HUVECs and MSCs were grown the 
farther apart (D2) show a significant increase in migratory activity. (e) CdM was used 
to supplement media for a tube formation assay. HUVECs incubated with CdM from 
coculture in which HUVECs and MSCs were grown separated but close (<200 µm) (D0, 
D1) formed a significantly longer network.e). Tube formation assays showed that 
HUVECs grown with medium supplemented with CdM from all coculture groups self-
assembled and elongated, forming a capillary-like network with typically closed 




HUVECs with CdM from D0 and D1 groups resulted in a longer network of tube-like 
structures.  
 Those findings seem to support the data collected in Figure 13: ECs grown in 
close (≤200µm) coculture condition show characteristics of a later stage 
angiogenesis. (a) Schematic of the experiment. Cells were collected from the 3D 
printed samples after 48h of incubation. HUVECs were sorted using CD31 MACS, and 
used in subsequent experiments. (b) FACS analysis, pre and post-separation. The 
bottom row confirms the positive selection of HUVECs (c) Rt-PCR showed an increase 
in gene expression of VEGF and FGF-2 for cells isolated from D2 samples and an 
increase in the fold change in mRNA of Ang-1 for cells isolated from D0/D1 samples. 
(d) Cell confluency after 24h of incubation. D2 cells exhibit a significantly higher 
proliferation rate than the other groups. (e) Permeabilization Assay. Diffusion of 
Dextran-FITC was observed through a confluent monolayer of HUVECs. Cells isolated 
from D2 samples showed the highest permeability. Rt PCR showed an increase in gene 
expression of ITGA5 for the same cells. . D0/D1 CdM promotes preferentially tube 
formation, a later stage of angiogenesis, due in part to a significant increase in Ang-1 
paracrine secretion. While CdM from D2 samples contains a lower concentration of 
VEGF/FGF than D0 or D1, still increased HUVECs significantly migration in a wound 
assay. This seems to further confirm that HUVECs grew in close (≤200µm) coculture 
condition show characteristics of a later stage angiogenesis. 
Since MSCs cultured in isolation produced more VEGFA and FGF2 than HUVECs 




create a gradient of paracrine secretions. And this gradient could also vary depending 
on the distance between fibers. This phenomenon could explain the difference in 
VEGF/FGF secretion between “mixed”, D0, D1, and D2 groups. Endothelial cell 
migration is mediated by VEGF gradients which orientates, attracts, and induces 
proliferation of new blood vessels 210–212. Furthermore, the shape of the VEGFA 
gradient can dictate the proliferation and migratory response exhibited by endothelial 
cells 213. Models predict that VEGF distribution along the gradient forms an uneven 
slope: cells close to the VEGF-A source would be in an exponential high concentration 
zone, while cells further away from the source would be in a zone of linear low 
concentration 214. In addition, analysis of cell migration in different regions of the 
applied gradients showed that cells efficiently interpret the positional information 
provided by the gradients 213: responses for both VEGFA and FGF2 were more 
pronounced in the exponential regions of the gradients compared with the linear 
regions. Based on those findings, we could hypothesize that D0/D1 cocultures formed 









Figure 14: The crosstalk between hMSC and HUVECs is regulated by the separation and distance of cell populations. 
(a) Schematic of the experiments. After 48h of incubation, CdM was collected and concentrated. Different growth 
factors concentration was measured using ELISAs. Finally the CdM was used to supplement media in functional 
Angiogenic assays. (b) Concentration of VEGFA, FGF-2 and Ang-1 in CdM from all experimental groups. For each growth 
factor, groups not sharing a letter are statistically different. Paracrine secretions were significantly increased in 
coculture groups where HUVECs were separated from MSCs (D0, D1). (c) CdM was used to supplement media in a 
proliferation assay. HUVECs confluency after 24h was measured. No statistical difference was observed between 
coculture groups. (d) CdM was used to supplement media for migration assay. Picture of the wound were taken 12h 
after “scratching” a confluent monolayer of HUVECs, and the wound closure was calculated. Groups incubated with 
CdM from coculture in which HUVECs and MSCs were grown the farther apart (D2) show a significant increase in 
migratory activity. (e) CdM was used to supplement media for a tube formation assay. HUVECs incubated with CdM 





EV cargo increases with distance between cell populations and promotes early 
angiogenesis. 
The third objective of this work was to study the angiogenic potential of 
extracellular vesicles (EVs) exchanged between cell populations. Many studies indicate 
EVs is a key mediator of the therapeutic functions imparted by cell therapies 215–217. 
Thus, we investigated whether EVs play a role in the angiogenic effects observed with 
CdM. EVs were isolated from the CdM using differential centrifugation and quantified 
(Figure 15: EVs cargo increases with distance between cell populations and 
promotes early angiogenesis. (a) EVs and protein per EVs quantification. Proteins 
concentration per EVs increases with the distance between cell populations in co-
culture. (b) Schematics of experiment. After 48h of incubation, CdM was collected 
from all experimental groups and EVs were collected by centrifugation. EVs were then 
quantified and their Angiogenic potential was evaluated in functional Angiogenic 
assays. (c) Tube Formation Assay. EVs supplemented media was used to incubate 
HUVECs on Matrigel. Total length of network formed by tube like structures was 
measured. No statistical difference was observed between coculture groups. (d) 
Proliferation Assay. EVs supplemented media was used to grown HUVECs. Confluency 
was measured after 24 and 48h of incubation. HUVECs grown with D2 EVs showed a 
higher proliferation rate. (e) Migration Assay. HUVECs grown in D2 EVs supplemented 
media showed a faster migration. a). The results showed a significant increase 
(p<0.05) in protein concentration per EVs in all separated co-culture groups (D0, D1, 




in protein concentration when compared to D0 or D1 groups. Which seems to suggest 
that EVs cargo content increases with the distance between HUVECs and MSCs. Figure 
13: ECs grown in close (≤200µm) coculture condition show characteristics of a later 
stage angiogenesis. (a) Schematic of the experiment. Cells were collected from the 3D 
printed samples after 48h of incubation. HUVECs were sorted using CD31 MACS, and 
used in subsequent experiments. (b) FACS analysis, pre and post-separation. The 
bottom row confirms the positive selection of HUVECs (c) Rt-PCR showed an increase 
in gene expression of VEGF and FGF-2 for cells isolated from D2 samples and an 
increase in the fold change in mRNA of Ang-1 for cells isolated from D0/D1 samples. 
(d) Cell confluency after 24h of incubation. D2 cells exhibit a significantly higher 
proliferation rate than the other groups. (e) Permeabilization Assay. Diffusion of 
Dextran-FITC was observed through a confluent monolayer of HUVECs. Cells isolated 
from D2 samples showed the highest permeability. Rt PCR showed an increase in gene 
expression of ITGA5 for the same cells.  indicated that ECs grown in D2 coculture 
conditions showed an important up-regulation of VEGFA and FGF2 genes. However, 
no significant increase in VEGF or FGF secretions were observed in the CdM (Figure 
14: The crosstalk between hMSC and HUVECs is regulated by the separation and 
distance of cell populations. (a) Schematic of the experiments. After 48h of 
incubation, CdM was collected and concentrated. Different growth factors 
concentration was measured using ELISAs. Finally the CdM was used to supplement 
media in functional Angiogenic assays. (b) Concentration of VEGFA, FGF-2 and Ang-1 




letter are statistically different. Paracrine secretions were significantly increased in 
coculture groups where HUVECs were separated from MSCs (D0, D1). (c) CdM was 
used to supplement media in a proliferation assay. HUVECs confluency after 24h was 
measured. No statistical difference was observed between coculture groups. (d) CdM 
was used to supplement media for migration assay. Picture of the wound were taken 
12h after “scratching” a confluent monolayer of HUVECs, and the wound closure was 
calculated. Groups incubated with CdM from coculture in which HUVECs and MSCs 
were grown the farther apart (D2) show a significant increase in migratory activity. (e) 
CdM was used to supplement media for a tube formation assay. HUVECs incubated 
with CdM from coculture in which HUVECs and MSCs were grown separated but close 
(<200 µm) (D0, D1) formed a significantly longer network.b). Altogether, it would 
indicate that most likely VEGF/FGF proteins or nucleic acids regulating these 
pathways were preferentially loaded into EVs in D2 cocultures. We could hypothesize 
that EVs secretion is preferred as a mode of cell-cell communication when cell 
populations are further apart.  
Functional angiogenic assays were performed to assess the angiogenic potential 
of EVs only. Media supplemented with EVs (normalized by EV protein concentration) 
was used to perform tube formation (Figure 15: EVs cargo increases with distance 
between cell populations and promotes early angiogenesis. (a) EVs and protein per 
EVs quantification. Proteins concentration per EVs increases with the distance 
between cell populations in co-culture. (b) Schematics of experiment. After 48h of 




by centrifugation. EVs were then quantified and their Angiogenic potential was 
evaluated in functional Angiogenic assays. (c) Tube Formation Assay. EVs 
supplemented media was used to incubate HUVECs on Matrigel. Total length of 
network formed by tube like structures was measured. No statistical difference was 
observed between coculture groups. (d) Proliferation Assay. EVs supplemented media 
was used to grown HUVECs. Confluency was measured after 24 and 48h of incubation. 
HUVECs grown with D2 EVs showed a higher proliferation rate. (e) Migration Assay. 
HUVECs grown in D2 EVs supplemented media showed a faster migration.c), 
proliferation (Figure 15: EVs cargo increases with distance between cell populations 
and promotes early angiogenesis. (a) EVs and protein per EVs quantification. Proteins 
concentration per EVs increases with the distance between cell populations in co-
culture. (b) Schematics of experiment. After 48h of incubation, CdM was collected 
from all experimental groups and EVs were collected by centrifugation. EVs were then 
quantified and their Angiogenic potential was evaluated in functional Angiogenic 
assays. (c) Tube Formation Assay. EVs supplemented media was used to incubate 
HUVECs on Matrigel. Total length of network formed by tube like structures was 
measured. No statistical difference was observed between coculture groups. (d) 
Proliferation Assay. EVs supplemented media was used to grown HUVECs. Confluency 
was measured after 24 and 48h of incubation. HUVECs grown with D2 EVs showed a 
higher proliferation rate. (e) Migration Assay. HUVECs grown in D2 EVs supplemented 
media showed a faster migration.d) and migration (Figure 15: EVs cargo increases 




protein per EVs quantification. Proteins concentration per EVs increases with the 
distance between cell populations in co-culture. (b) Schematics of experiment. After 
48h of incubation, CdM was collected from all experimental groups and EVs were 
collected by centrifugation. EVs were then quantified and their Angiogenic potential 
was evaluated in functional Angiogenic assays. (c) Tube Formation Assay. EVs 
supplemented media was used to incubate HUVECs on Matrigel. Total length of 
network formed by tube like structures was measured. No statistical difference was 
observed between coculture groups. (d) Proliferation Assay. EVs supplemented media 
was used to grown HUVECs. Confluency was measured after 24 and 48h of incubation. 
HUVECs grown with D2 EVs showed a higher proliferation rate. (e) Migration Assay. 
HUVECs grown in D2 EVs supplemented media showed a faster migration.e) assays. 
Results indicated that media supplemented with D2 EVs significantly improved 
HUVECs proliferation and migration in comparison to Mix, D0, or D1. HUVECs 
proliferation after 24h seemed to be correlated to EV proteins concentration 
(r2=0.9551) (Figure 14: The crosstalk between hMSC and HUVECs is regulated by the 
separation and distance of cell populations. (a) Schematic of the experiments. After 
48h of incubation, CdM was collected and concentrated. Different growth factors 
concentration was measured using ELISAs. Finally the CdM was used to supplement 
media in functional Angiogenic assays. (b) Concentration of VEGFA, FGF-2 and Ang-1 
in CdM from all experimental groups. For each growth factor, groups not sharing a 
letter are statistically different. Paracrine secretions were significantly increased in 




used to supplement media in a proliferation assay. HUVECs confluency after 24h was 
measured. No statistical difference was observed between coculture groups. (d) CdM 
was used to supplement media for migration assay. Picture of the wound were taken 
12h after “scratching” a confluent monolayer of HUVECs, and the wound closure was 
calculated. Groups incubated with CdM from coculture in which HUVECs and MSCs 
were grown the farther apart (D2) show a significant increase in migratory activity. (e) 
CdM was used to supplement media for a tube formation assay. HUVECs incubated 
with CdM from coculture in which HUVECs and MSCs were grown separated but close 
(<200 µm) (D0, D1) formed a significantly longer network.d). However, no significant 
effect on tube formation was observed. As discussed previously, VEGF and FGF are 
both involved in early angiogenesis, promoting EC proliferation and migration. Those 
results would further suggest that either VEGF/FGF or other nucleic acids involved in 
these pathways were loaded in EVs for farther apart co-culture (D2).  
Evidence seems to indicate that in coculture where cells are the farther apart, 
EVS is preferred for cell-cell communication. This could explain why angiogenesis is 
happening slower than groups D0, D1. This study appears to indicate that EVs are 
largely involved in cell-cell communication in cocultures where the cells are farther 
apart, while paracrine signaling via soluble proteins is dominant when the cells are 
closer together. The mode of cell-cell communication may dominate the rate of 
angiogenesis. VEGF, FGF-2, and Ang1 can act upon target cells by interacting with 
receptors on the cell surface. Depending on whether the function of these EVs is 
imparted by surface proteins or internal cargo, they may need to initially be processed 













Figure 15: EVs cargo increases with distance between cell populations and promotes early angiogenesis. (a) EVs and 
protein per EVs quantification. Proteins concentration per EVs increases with the distance between cell populations 
in co-culture. (b) Schematics of experiment. After 48h of incubation, CdM was collected from all experimental groups 
and EVs were collected by centrifugation. EVs were then quantified and their Angiogenic potential was evaluated in 
functional Angiogenic assays. (c) Tube Formation Assay. EVs supplemented media was used to incubate HUVECs on 
Matrigel. Total length of network formed by tube like structures was measured. No statistical difference was observed 
between coculture groups. (d) Proliferation Assay. EVs supplemented media was used to grown HUVECs. Confluency 
was measured after 24 and 48h of incubation. HUVECs grown with D2 EVs showed a higher proliferation rate. (e) 






These results suggest that controlling the distance between ECs and MSCs in 
coculture, using 3D printing, can influence angiogenesis. We showed that HUVECs 
grown in close (≤200µm) coculture condition presented characteristics of later stage 
angiogenesis: Ang-1 and VE-cadherin were upregulated, and paracrine secretion used 
to culture HUVECs on Matrigel formed significantly longer a network of tube-like 
structures. However, HUVECs grown farther apart from MSCs (400µm) showed 
characteristics of earlier stages of angiogenesis: both VEGF and FGF-2 were 
upregulated, and HUVECs grown in media supplemented with CdM or EVs from D2 
groups presented a significantly higher mitotic activity and migration rate. In addition, 
the separation and distance between ECs and MSCs seemed to modulate cell-cell 
communication. In groups in which fibers were printed the farther apart (400µm), cells 
produced EVs with a significantly increase cargo.  Finally, by modulating distance 
between printed fibers, results indicated that we can create different paracrine secretion 
gradients, hence modulate the crosstalk between HUVECS and MSCs. Further 
experiments should be performed to better understand the mechanism behind the 
phenomenon observed, such as why exactly is EVs communication is increased when 






Chapter 6:  Repair of Calvarial Defects in Rats with Optimized 
3D Printed EC-MSCs Cocultures  
 
Introduction 
Based on the concepts and findings from Chapter 4 and Chapter 5, this study 
was designed to determine whether optimized concentric 3D printed (3DP) cocultures 
could support osteogenic differentiation and consequent bone regeneration, as well as 
proper neovascularization, in an in vivo model. A calvarial rat model was chosen as it 
is a well-documented model for the evaluation of bone healing.  The critical size defect 
in rat calvaria is the smallest diameter of the intraosseous wound that does not heal 
spontaneously. Defects of 8 mm created surgically in the rat’s calvaria by Takagi and 
Urist 218 showed healing by connective fibrous tissue after 6 months. The defect was 
reduced to 5 mm in four weeks, but no further healing of the defect was noted thereafter. 
In addition, Hollinger and Kleinschmidt 219 found that after 13 months of healing, an 8 
mm cranial defect in Long–Evans rats did not heal spontaneously.  
In this study, 3DP samples, alternating fibers containing endothelial cells (ECs) and 
mesenchymal stem cells (MSCs) were implanted in a calvarial rat defect, and retrieve 
after 12 weeks. Histological analysis was performed for identification of new osteoid 
matrix within the injury site and analyzed for quantification of new bone formation and 





Material and Methods 
Cell Culture 
Rat primary aortic endothelial cells (RAECs) were purchased from Cell Biologics 
(Chicago, IL) and cultured according to manufacturer instructions.  Rat  MSCs  
(rMSCs) were purchased from  RD  Systems (Minneapolis, MN) and cultured in 
osteogenic media for 7 days prior to implantation. The osteogenic media was 
formulated by supplementing growth media with 100 nM dexamethasone (Sigma, St. 
Louis, MO), 10 mM β‐glycerophosphate (Sigma), and 173 mM ascorbic acid (Sigma).  
Cells were expanded on tissue culture polystyrene flasks with media changes every 3 
days and grown to 80% confluency before being passaged using trypsin/EDTA. Cells 
at passage P4 were used for the experiments.   
3D Printed Samples Preparation 
Scaffolds for in vivo evaluation were fabricated using a commercial extrusion-based 
3D printer (3D Bioplotter, EnvisionTEC, Gladbeck, Germany). All printing supply 
(30cc barrel and 200 µm/400 µm precision tips) were purchased from Nordson EFD 
(RI, USA).  
All samples were about 0.7 mm in thickness and 8 mm in diameter (Figure 16). 
Fibrinogen and thrombin from bovine plasma were purchased from Sigma. Type A 
porcine gelatin (300g Bloom) was purchased from Sigma. The bioink was prepared by 
mixing 10 w/v% fibrinogen and 5w/v% gelatin and heating to 60°C for 15 min. Cells 
were passaged, suspended in media and centrifuged to form a pellet. After aspiration 




until the solution was homogenous and all clumps were broken down.  Fibrin bioink 
encapsulating 2x106 rMSCs/ml or 2x106 RAECs/ml were used to print experimental 
samples. Fibrin bioink encapsulating 2x106 rMSCs-RAECs/ml (ratio 1:1) were used to 
print control samples. All bioinks were loaded into separate print heads and were heated 
to 22°C for 30 min prior to printing. Printed constructs were crosslinked in 100 U 
thrombin for 30 min. All of the above was performed under sterile conditions.  
Live/Dead Assay 
3DP samples, prepared as explained above, were used to assess in vitro cell viability 
directly after printing.  Cell viability was assessed using a Live/Dead assay (Invitrogen) 
following the manufacturer’s protocol. Briefly, samples were incubated with 2 µM 
ethidium homodimer and 4 µM calcein AM for 1 h. Fluorescent images were taken 
using a confocal microscope (Leica SP5 X). Live cells appeared green while the dead 
ones were red.  
Animal Implantation 
The Institutional Animal Care and Use Committee of the University of Maryland 
approved the study (protocol number R-MAY-18-26), and all animals were treated in 
accordance with the Guide for the Care and Use of Laboratory Animals. The 
experiment was conducted in 30 male adult Sprague Dawley rats.  
Implantation was explained elsewhere 220. Briefly, the fur on the bridge of the snout 
between the eyes to the caudal end of the calvarium was shaved to expose the surgical 
site. Using a scalpel, an incision of approximately 1.5 cm was made over the scalp from 




The underlying bone was exposed. The calvarium was scored with a surgical drill while 
being irrigated with sterile normal saline to form an 8 mm diameter defect on the 
sagittal suture. Once the calvarium was freed, it was raised off the dura to finish the 
defect. The defect was washed with sterile normal saline to remove any debris and/or 
bone chips. The scaffold was placed into the defects and the wound was closed over 
the implant using a running 4-0 monocryl suture. Control animals (CT) underwent 
sham surgery exactly as described but without implanting the scaffold material.  For 
these animals undergoing cranial window implantation, after a scaffold was placed 
inside the defect, a circular glass coverslip was placed to cover the implant. The optical 
window was sealed to the skull with cyanoacrylate, covering all the exposed skull, 
wound margins and cover glass edges 221. Animals were monitored daily for up to 12 
weeks. No complications were reported.  
Histological Analysis 
At 4 and 12 days post implantation, animals were euthanized by inhalation of CO2 and 
the samples and surrounding bone tissue were explanted. Each explanted tissue sample 
was fixed in paraformaldehyde (4%), decalcified in 20% EDTA, and embedded in 
paraffin for histological analysis. Explanted tissue samples were prepared and sliced 
(15 µm slides) by Histoserv, Inc. (Germantown, MD). For histological evaluation, 
sections were rehydrated in consecutive ethanol washes and stained by Masson's 
trichrome staining and Hematoxylin/Eosin. The thickness of the defect, the length of 
the newly formed bone and the number of blood vessels for each sample were measured 





For each animal, the length of the new bone formed was calculated over 3 different 
sections/samples: a total of 9 measurements (n=12) were taken for each group. For both 
the thickness of the defect and the number of blood vessel per area, measurements were 
taken in two different areas/section, with 3 sections/sample: a total of 18 measurements 
were taken for each group.  
The ANOVA test for variance analysis was performed followed by Tukey’s Multiple 
Comparison Test assuming normal data distribution with a confidence of 95% 
(p<0.05).  
Results 
Healing of critical-size bone defect on visual examination. 
The aim of this chapter was to determine whether optimized concentric 3D 
printed (3DP) cocultures could support osteogenic differentiation and consequent bone 
regeneration, as well as proper neovascularization, in an in vivo model. 8-mm bone 
defects were created in the calvarial bones of rats. Two experimental groups and one 
control group were assayed at twelve weeks post calvarial defect. The cranial bones 
were harvested at 12 weeks after the creation of bone defects.  
 Implanted samples were 8 mm by 0.7 mm discs. Two experimental groups were 
prepared. Schematics of each are shown in Figure 16a. The first group (control) 
consisted of concentric fibers, printed using a fibrin bioink (described in Chapter 4) 
encapsulating both rat ECs and rat MSCs, with a ratio of 1:1. The second, experimental 
group consisted of concentric fibers, alternating bioink encapsulating either rat ECs or 




post-printing, and prior to implantation. Fluorescent images showed mostly viable cells 
(Figure 16). In order to confirm the proper patterning of the cells, rMSCs and rECs 
were stained with Calcein AM or DAPI respectively, prior to printing. After printing, 
samples were imaged (Figure 16c).  
 All wounds healed without any complications, or evidence of infection. At 
retrieval, samples appeared to be covered by a healthy periosteum. No signs of 
inflammation were visible. On visual examination (Figure 17), the critical size defect 
left unfilled (CT) was not closed, the sagittal vein and peripheral blood vessels were 
clearly visible. New tissue formation was visible only on the edges of the defect. 
Defects in both 3D printed controls (CT-3DP) and experimental group (EXP-3DP) 
appeared to have nearly closed. However, the sagittal vein was still slightly visible in 
the CT-3DP group, suggesting that the newly formed tissue might be thinner than in 
the EXP-3DP group.  
Healing of critical-size bone defect on histological analysis. 
The densities of blood vessels present in all scaffolds were measured 4 weeks 
after implantation. Histological sections stained with HE showed relatively few blood 
vessels within the control scaffolds (Figure 18a). In contrast, 3DP scaffolds displayed 
a higher density of blood vessels interspersed throughout the scaffold. Quantification 
of blood vessels densities confirmed that 3DP-EXP scaffolds had a significantly higher 
blood vessel density than 3DP-CT and CT scaffolds (Figure 18b).  
The effect of induces angiogenesis on bone tissue regeneration within the 




samples was performed using a Masson’s trichrome stain. Using this method, 
mineralized bone is stained dark blue while osteoids, or unmineralized bone tissue, are 
stained pink/red. Collagen fibers are also stained blue. Cytoplasm is stained pink and 
cell nuclei black. Gross observations of the Masson’s trichrome stained slides showed 
only minimal appositional bone regeneration and a thin layer of fibrous tissue and 
obvious defects remaining in the control group (Figure 19a). 3DP samples showed 
significantly enhanced bone growth as compared to controls ones. Histomorphometric 
analysis corroborated the histological findings (Figure 19b). The length and thickness 
of the newly formed bone in defect sites were calculated. The results indicated that 
3DP-EXP groups were significantly thicker than the 3DP-CT and CT groups. However, 





   
Figure 16:  Methods. (a) Schematics of the 3D printed samples. Discs were 8 mm in diameter and 0.7mm 
thick, and made of concentric fibers (200 µm) with no space between fibers. Control groups were printed 
using a bioink containing a mix of RAECs and MSCs (ratio 1:1). Experimental groups were printed using two 
different bioinks, one containing MSCs, the other containing RAECs; fibers were alternated. (b) Live/Dead 
Micrograph of 3DP samples. Live cell were stained with Calcein AM (green) and dead cells were stained with 
ethidium homodimer (red). Cell viability was high after printing. (c) Experimental group, MSCs were stained 





Figure 17: Sample implantation in rat calvarial defects, and extraction. The left panel shows pictures taken during 
surgery. In order, the exposed skull prior to drilling, the critical size defect, and finally the critical size defect filled 
with a 3D printed sample. Sham surgery was performed on CT group, leaving the defect empty. The right panel 





Figure 18: Optimized 3DP coculture enhanced blood vessel ingrowth after 4 weeks. (a) 





Figure 19: Representative images of Masson’s trichrome stained slides. New bone formed and bone thickness 





Masson’s trichrome stained slices of repaired tissues showed that the EXP-3DP groups 
could not only stimulate regeneration of new bone but also regenerate a larger amount 
of bone defect than the control group. No significant difference in the amount was 
observed between both 3DP groups.  
However, a significantly higher number of blood vessels was observed in EXP-3DP 
when compared to CT-3DP. This observation suggests the higher efficiency of indirect 
ECs/MSCs contact in prompting the release of paracrine signals that stimulate the 






Chapter 7:  Summary and Future Directions  
 
Summary 
In Chapter 2, we demonstrated the successful fabrication of calcium deficient 
hydroxyapatite microparticles, with biological properties closer to the bone than 
stoichiometric, commercially available hydroxyapatite. This CDHAP exhibited a well-
defined 3D network of crystalline nanoplates forming mesoporous and hollow 
structures. The high specific area created by those structures enabled us to load VEGF 
with high efficiency and sustained drug release property when compared to the loading 
efficiency of SBp. Additionally, we demonstrated that VEGF-CDHAp could be used 
to improve both osteogenesis and angiogenesis in vitro. These CDHAp have held great 
potentials for drug-delivery applications and could be used to deliver not only VEGF 
but also multiple bioactive growth factors. They could find broad utility in many bone 
tissue engineering applications where sustained release of factors in a local 
environment is advantageous.    
In Chapter 4, we developed and optimized a fibrin bioink, with potential 
applications going beyond bone tissue engineering. Fibrin is a natural polymer known 
to support wound healing by inducing angiogenesis and promoting cell attachment and 
proliferation, and therefore an attractive matrix for stem cell differentiation and tissue 
engineering. We also demonstrated the successful fabrication of a novel 3DP fibrin-
PCL composite scaffold, with mechanical strength comparable to bone, a stable 




By using 3D printing technologies, we were able to successfully patterned bioinks into 
varied geometries and with controlled dimensions, in order to recreate an optimal 
microenvironment mimicking the native natural cell pattern found in bones, to form a 
simplified model of osteons. These results lead us to believe that cell placement or 
patterning could play a critical role in neovascularization. Most importantly, the 
utilization of these scaffolds in constructing bio-inspired osteons for bone regeneration 
demonstrated a promising capacity to improve neovascularization of the construct. This 
bio-inspired osteon-like construct holds potential to be developed as scaffolds in 
vascularized bone tissue engineering.  
In Chapter 5, we investigated the role of distance between cell populations, 
introduced via 3D printing, in ECs/MSCs crosstalk. Our results suggested that 
controlling the distance between ECs and MSCs in coculture, using 3D printing, could 
influence angiogenesis. We showed that HUVECs grown in close (≤200µm) coculture 
condition presented characteristics of later stage angiogenesis: Ang-1 and VE-cadherin 
were upregulated, and paracrine secretion used to culture HUVECs on Matrigel formed 
significantly longer a network of tube-like structures. In addition, the separation and 
distance between ECs and MSCs seemed to modulate cell-cell communication. In 
groups in which fibers were printed the farther apart (400µm), cells produced EVs with 
a significantly increase cargo.  Finally, by modulating distance between printed fibers, 
results indicated that we could create different paracrine secretion gradients, hence 
modulate the crosstalk between HUVECS and MSCs. Combining the technology 
developed in chapter 4 and the findings of chapter 5, we determine whether optimized 




consequent bone regeneration, as well as proper neovascularization, in a critical size 
rat cranial defect.   
 
Future Directions 
3D printed gradient of VEGF using CDHAp 
It has been shown that in order to control vascular organization, it is not so 
much the availability of VEGF, but the presence of gradients that controls vascular 
migration 222. By creating distinct patterns of VEGF onto scaffolds or within hydrogels, 
gradients can be instituted, resulting in spatially driven endothelial cell elongation and 
branching 223,224. The mesoporous calcium deficient hydroxyapatite developed in 
Chapter 2, presents high capacity for drug loading and show great potential as candidate 
carriers for VEGF release. The 3D printing of these osteoinductive microparticles in 
specific patterns could be used as a novel way to deliver gradient of VEGF to ECs and 
MSCs, and to improve ECs invasion and sprouting throughout a 3DP scaffold, and 
hence the development of a stable microvasculature.   
Synergistic effect of CDHAp and ECs/MSCs coculture 
In this manuscript, we focused on two avenues to improve the 
neovascularization of bone tissue constructs: (1) the development of osteoinductive 
mesoporous microparticles, and (2) the optimization of ECs/MSCs coculture, utilizing 
the capabilities of 3D printing, and based on a bio-inspired strategy. The next step could 




containing MSCs, ECs, and CDHAp improves the formation of a pre-vascular network 
due to the synergetic effects of improved VEGF delivery and paracrine signaling. 
Developing new bio-inspired bioinks for 3D printing 
Biomimicry is based on the fact that the intrinsic properties of biomaterials need to 
mimic the 3D microenvironment of the native tissue in terms of topographical, 
biological and physicomechanical features, in order to provide instructing cues to 
surrounding cells to stimulate their adhesion, migration, proliferation, and 
differentiation. In this dissertation, we mainly focused on recreating units found in 
bones (osteons), i.e. in mimicking the native cell patterning of cortical bones. To do so, 
we used a fibrin bioink.  
However, as mentioned previously, the bone extracellular matrix is a nanocomposite 
of organic and inorganic elements. Bones are composed of 65 % by weight of minerals, 
primarily carbonated apatite and 20-25% of organic components. Bone organic phase 
mainly consists of collagen I. In order to increase the biomimecry of our 3DP osteons, 
one approach would be to develop bio-inspired inks for 3D printing.  An optimal 
strategy would be to decellularize bone natural  ECM (dECM) to eliminate 
immunogenicity and co-print dECM with biocompatible  hydrogels and cells in an 
attempt to provide physiological conditions of native tissues. Cell-laden ECM 
hydrogels were successfully developed for 3D printing and co-printed with 
polycaprolactone to develop functional cartilage, heart and adipose tissue 225.  In a 
recent study, 3D printing of bone dECM on porous scaffolds was found to promote 




Another strategy to improve bioinks for bone printing would be the use of mineralized 
collagen. Based on the understanding of natural mineralized collagen and its formation 
process, many studies developed bio-inspired materials mimicking natural mineralized 
collagen 228,229. Several protocols have been developed to synthesized an HA and 
collagen composite 230. Interestingly, some of those methods are very similar to the one 
used in Chapter 2 to form CDHA. It consists of precipitating calcium phosphate directly 
around collagen fibrils, by gradually adding calcium and phosphate to a collagen-fibril-
containing medium at an elevated pH value 231. Cui et al. designed and prepared bio-
inspired mineralized collagen nano-fibrils that was similar to the natural bone in terms 
of both the composition and the nanostructure: the mineralized collagen fibrils aligned 
parallel to each other to form mineralized collagen fibers 232. The bone remodeling 
ability of mineralized collagen was evaluated in both a segmental defect rabbit model 
(long bone) 233 and a sheep cranial defect 234. In both cases, the results showed that the 
bio-inspired mineralized collagen repaired the critical defect.  
The use of this bio-inspired material is limited, and to the best of my knowledge has 






Appendix 1:  A brief summary of bone biology.  
Bone is an organ composed of bone tissue, bone marrow, epithelium, blood vessels, 
and nerves. Its mechanical function is the most widely recognized and studied, but 
bones also played a major role in hematopoiesis and mineral, phosphate and glucose 
homeostasis 4. On the macroscopic scale, bone is made of dense cortical bone forming 
an outside shell and cancellous bone within the marrow cavity. The more porous 
trabecular bone, found in the metaphysis of bones, presents a large surface area and is 
responsible for the long term control of calcium and phosphate balance. The dense 
cortical bone, mostly found in the diaphysis of bones, comprises most of the bone mass 
and takes on most of the role for load bearing and protection 235.  
 
Bone multiscale organization 
To achieve those fundamental functions, bones are organized in a hierarchical manner. 
On the microscale level, cortical bone is composed of many Haversian systems or 
osteons that are the product of bone resorption and replacement 236. Those osteons are 
composed of a central canal, the Haversian canal, carrying the blood vessels, 
surrounded by layers of concentric lamellae. Bone cells are arranged in several circular 
layers around the vascular canal. Mature osteons are between 100 and 250µm 
diameters, corresponding to 20 to 25 lamellae, and measure from 1 to 10mm in length. 
On the nanoscale level, lamellae are composed of collagen fibers with plates of mineral 




of molecules forming a triple helix composed of two α1 chains and a single α2 chain 
237. 
Figure 20: Bone multiscale organization. Cortical bone is made of an assembly of modular structures called 
osteons. Which is also a geometrically efficient system for supplying blood. 
 
Bone tissue composition 
Bones are composed of 65 % by weight of minerals, primarily carbonated apatite and 
20-25% of organic components. The remainder 10% is composed of water that is bound 
to the collagen-mineral composite. The organic phase in made of 90% type I collagen. 
The remaining 10% is made up of non-collagenous proteins (NCPs) which play a vital 
role in regulating collagen formation and fibril size, mineralization, and cell attachment 
238. Among NCPs, the most notables are proteoglycans, glycoproteins, such as alkaline 
phosphatase (ALP), osteopontin, osteocalcin (OCN), fibronectin and osteonectin.  ALP 
is used as a biomarker for bone formation as it hydrolyzes pyrophosphates in bone, 
allowing normal crystal growth and mineralization.  Osteopontin is secreted in the early 
stages of osteogenesis, inhibiting the mineral formation and crystal growth. Osteocalcin 




The mineral phase is initially deposited as an amorphous of calcium phosphate. Bone 
mineral starts to nucleate into the holes and pores present in the collagen fibrils and is 
catalyzed by the presence of phosphated esters groups and carboxylate groups present 
in the collagen fibrils. Thereafter, as bone tissue mature the carbonate content is 
reduced and mineral crystals grow, becoming more plate-like, and eventually 
interconnecting all of the collagen fibrils. Mineral crystals in bone are on average 20-
50 nm long, 15 nm wide and 2-5 nm thick.  
During mineralization, minerals rapidly deposited within the collagen framework, 
achieving 65-70% of its total mineralization within about 3 weeks after initial 
deposition of collagen. As a major component of bone, hydroxyapatite may possess 
certain biochemical moieties capable of interacting with cell surface proteins. 
Bone cells 
Four types of cells are found within the bone matrix: osteoclasts, osteoblasts, lining 
cells and osteocytes. Osteoclasts function as bone resorbing cells. Osteoblasts are the 
cells responsible for bone formation, carrying out the function of bone matrix proteins 
secretion and bone mineralization. Once the bone matrix completed, some mature 
osteoblasts remain entrapped in bone as osteocytes, and some flatten to cover the 
quiescent bone surface as bone lining cells 239.  
Osteoblasts originate from mesenchymal progenitors, found mostly in the bone 
marrow. The commitment of mesenchymal stem cells to the osteoblastic lineage starts 
by their differentiation into osteoprogenitor cells and depends on specific activation of 
transcription factors induced by morphogenetic and development proteins 240. At this 




Osteoprogenitor cells then transition into pre-osteoblast cells, corresponding to an up-
regulation of alkaline phosphatase (ALP) and runt-related transcription factor 2 
(Runx2) 242. Finally, pre-osteoblast cells mature into osteoblasts. Runx2 and osterix 
both up-regulated at this stage, are essential for establishing the osteoblasts phenotype 
by regulating the expression of a gene that controls bone formation and remodeling 
(osteocalcin, osteopontin, MMP13) 242,243. The runx2 signaling pathway is activated by 
Wnts and BMP2 244. ALP is often used as a biomarker of osteogenic differentiation: 
ALP is expressed early in development, where it is observed on the cell surface and in 
matrix vesicles. While later during the differentiation of MSCs into osteoblasts, other 
genes such as osteocalcin are upregulated and ALP expression declines. ALP is among 
the first functional genes expressed in the process of calcification. It is therefore likely 
that at least one of its roles in the mineralization process occurs at an early step 245.  
Bone blood supply 
In calcified tissues, cells must be within 250µm of their blood supply, as nutrients 
cannot diffuse rapidly through the dense mineralized tissue. The circular arrangement 
of cells in osteons around a central Haversian canal provides a geometrically efficient 
system for supplying the maximum amount of bone tissue, from the minimum number 
of vessels 246. Vessels in bones have the structural characteristics of capillaries: their 
walls contain no smooth muscle cells, and they are lined by an incomplete layer of 
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